Prenatal	O
immune	O
challenge	O
alters	O
the	O
hypothalamic-pituitary-adrenocortical	O
axis	O
in	O
adult	O
rats	O
.	O

We	O
investigated	O
whether	O
non-abortive	O
maternal	O
infections	O
would	O
compromise	O
fetal	O
brain	O
development	O
and	O
alter	O
hypothalamic-pituitary-adrenocortical	O
(	O
HPA	O
)	O
axis	O
functioning	O
when	O
adult	O
.	O

To	O
study	O
putative	O
teratogenic	O
effects	O
of	O
a	O
T	O
cell-mediated	O
immune	O
response	O
versus	O
an	O
endotoxic	O
challenge	O
,	O
10-d-pregnant	O
rats	O
received	O
a	O
single	O
intraperitoneal	O
injection	O
of	O
5	O
x	O
10	O
(	O
8	O
)	O
human	B-cell_type
red	I-cell_type
blood	I-cell_type
cells	I-cell_type
(	O
HRBC	B-cell_type
)	O
or	O
gram-negative	O
bacterial	O
endotoxin	O
(	O
Escherichia	O
coli	O
LPS	O
:	O
30	O
micrograms/kg	O
)	O
.	O

The	O
adult	O
male	O
progeny	O
(	O
3	O
mo	O
old	O
)	O
of	O
both	O
experimental	O
groups	O
showed	O
increased	O
basal	O
plasma	O
corticosterone	O
levels	O
.	O

In	O
addition	O
,	O
after	O
novelty	O
stress	O
the	O
HRBC	B-cell_type
group	O
,	O
but	O
not	O
the	O
LPS	B-cell_line
group	I-cell_line
,	O
showed	O
increased	O
ACTH	O
and	O
corticosterone	O
levels	O
.	O

Both	O
groups	O
showed	O
substantial	O
decreases	O
in	O
mineralocorticoid	O
(	O
MR	O
)	O
and	O
glucocorticoid	O
receptor	O
(	O
GR	O
)	O
levels	O
in	O
the	O
hippocampus	O
,	O
a	O
limbic	O
brain	O
structure	O
critical	O
for	O
HPA	O
axis	O
regulation	O
,	O
whereas	O
GR	B-protein
concentrations	O
in	O
the	O
hypothalamus	O
were	O
unchanged	O
and	O
in	O
anterior	O
pituitary	O
were	O
slightly	O
increased	O
.	O

HRBC	B-cell_type
and	O
LPS	O
indeed	O
stimulated	O
the	O
maternal	O
immune	O
system	O
as	O
revealed	O
by	O
specific	O
anti-HRBC	B-protein
antibody	I-protein
production	O
and	O
enhanced	O
IL-1	O
beta	O
mRNA	O
expression	O
in	O
splenocytes	B-cell_type
,	O
respectively	O
.	O

This	O
study	O
demonstrates	O
that	O
a	O
T	O
cell-mediated	O
immune	O
response	O
as	O
well	O
as	O
an	O
endotoxic	O
challenge	O
during	O
pregnancy	O
can	O
induce	O
anomalies	O
in	O
HPA	O
axis	O
function	O
in	O
adulthood	O
.	O

Clinically	O
,	O
it	O
may	O
be	O
postulated	O
that	O
disturbed	O
fetal	O
brain	O
development	O
due	O
to	O
prenatal	O
immune	O
challenge	O
increases	O
the	O
vulnerability	O
to	O
develop	O
mental	O
illness	O
involving	O
inadequate	O
responses	O
to	O
stress	O
.	O

Prenatal	NULL
Immune	NULL
Challenge	NULL
Alters	NULL
the	NULL
Hypothalamic-Pituitary-Adrenocortical	NULL
Axis	NULL
in	NULL
Adult	NULL
Rats	NULL
Johannes	NULL
M.	NULL
H.	NULL
M.	NULL
Reul	NULL
,	NULL
Ingemar	NULL
Stec	NULL
,	NULL
G.	NULL
Jan	NULL
Wiegers	NULL
,	NULL
Marta	NULL
S.	NULL
Labeur	NULL
,	NULL
Astrid	NULL
C.	NULL
E.	NULL
Linthorst	NULL
,	NULL
Eduardo	NULL
Arzt	NULL
,	NULL
and	NULL
Florian	NULL
Holsboer	NULL
Max	NULL
Planck	NULL
Institute	NULL
of	NULL
Psychiatry	NULL
,	NULL
Clinical	NULL
Institute	NULL
,	NULL
Department	NULL
of	NULL
Neurcendocrinology	NULL
,	NULL
80804	NULL
Munich	NULL
,	NULL
Federal	NULL
Republic	NULL
of	NULL
Germany	NULL
Abstract	NULL
We	NULL
investigated	NULL
whether	NULL
non-abortive	NULL
maternal	NULL
infections	NULL
would	NULL
compromise	NULL
fetal	NULL
brain	NULL
development	NULL
and	NULL
alter	NULL
hypothalamic-pituitary-adrenocortical	NULL
(	NULL
HPA	NULL
)	NULL
axis	NULL
functioning	NULL
when	NULL
adult	NULL
.	NULL

To	NULL
study	NULL
putative	NULL
teratogenic	NULL
effects	NULL
of	NULL
a	NULL
T	NULL
cell-mediated	NULL
immune	NULL
response	NULL
versus	NULL
an	NULL
endotoxic	NULL
challenge	NULL
,	NULL
10-d-pregnant	NULL
rats	NULL
received	NULL
a	NULL
single	NULL
intraperitoneal	NULL
injection	NULL
of	NULL
5	NULL
%	NULL
10°	NULL
human	NULL
red	NULL
blood	NULL
cells	NULL
(	NULL
HRBC	NULL
)	NULL
or	NULL
gram-negative	NULL
bacterial	NULL
endotoxin	NULL
(	NULL
Escherichia	NULL
coli	NULL
LPS	NULL
;	NULL
30	NULL
ug/kg	NULL
)	NULL
.	NULL

The	NULL
adult	NULL
male	NULL
progeny	NULL
(	NULL
3	NULL
mo	NULL
old	NULL
)	NULL
of	NULL
both	NULL
experimental	NULL
groups	NULL
showed	NULL
increased	NULL
basal	NULL
plasma	NULL
corticosterone	NULL
levels	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
after	NULL
novelty	NULL
stress	NULL
the	NULL
HRBC	NULL
group	NULL
,	NULL
but	NULL
not	NULL
the	NULL
LPS	NULL
group	NULL
,	NULL
showed	NULL
increased	NULL
ACTH	NULL
and	NULL
corticosterone	NULL
levels	NULL
.	NULL

Both	NULL
groups	NULL
showed	NULL
substantial	NULL
decreases	NULL
in	NULL
mineralocorticoid	NULL
(	NULL
MR	NULL
)	NULL
and	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
GR	NULL
)	NULL
levels	NULL
in	NULL
the	NULL
hippocampus	NULL
,	NULL
a	NULL
limbic	NULL
brain	NULL
structure	NULL
critical	NULL
for	NULL
HPA	NULL
axis	NULL
regulation	NULL
,	NULL
whereas	NULL
GR	NULL
concentrations	NULL
in	NULL
the	NULL
hypothalamus	NULL
were	NULL
unchanged	NULL
and	NULL
in	NULL
anterior	NULL
pituitary	NULL
were	NULL
slightly	NULL
increased	NULL
.	NULL

HRBC	NULL
and	NULL
LPS	NULL
indeed	NULL
stimulated	NULL
the	NULL
maternal	NULL
immune	NULL
system	NULL
as	NULL
revealed	NULL
by	NULL
specific	NULL
anti-HRBC	NULL
antibody	NULL
production	NULL
and	NULL
enhanced	NULL
IL-1	NULL
}	NULL
mRNA	NULL
expression	NULL
in	NULL
splenocytes	NULL
,	NULL
respectively	NULL
.	NULL

This	NULL
study	NULL
demonstrates	NULL
that	NULL
a	NULL
T	NULL
cell-mediated	NULL
immune	NULL
response	NULL
as	NULL
well	NULL
as	NULL
an	NULL
endotoxic	NULL
challenge	NULL
during	NULL
pregnancy	NULL
can	NULL
induce	NULL
anomalies	NULL
in	NULL
HPA	NULL
axis	NULL
function	NULL
in	NULL
adulthood	NULL
.	NULL

Clinically	NULL
,	NULL
it	NULL
may	NULL
be	NULL
postulated	NULL
that	NULL
disturbed	NULL
fetal	NULL
brain	NULL
development	NULL
due	NULL
to	NULL
prenatal	NULL
immune	NULL
challenge	NULL
increases	NULL
the	NULL
vulnerability	NULL
to	NULL
develop	NULL
mental	NULL
illness	NULL
involving	NULL
inadequate	NULL
responses	NULL
to	NULL
stress	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1994	NULL
.	NULL

93:2600-2607	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
T	NULL
cell-mediated	NULL
immune	NULL
response	NULL
*	NULL
endotoxic	NULL
challenge	NULL
»	NULL
pregnancy	NULL
»	NULL
corticosteroid	NULL
receptor	NULL
»	NULL
brain	NULL
development	NULL
Introduction	NULL
It	NULL
has	NULL
been	NULL
known	NULL
for	NULL
many	NULL
years	NULL
that	NULL
maternal	NULL
infection	NULL
associated	NULL
with	NULL
severe	NULL
systemic	NULL
illness	NULL
can	NULL
cause	NULL
abortion	NULL
,	NULL
perinatal	NULL
mortality	NULL
,	NULL
and	NULL
fetal	NULL
resorption	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
fetus	NULL
is	NULL
regarded	NULL
by	NULL
the	NULL
maternal	NULL
immune	NULL
system	NULL
as	NULL
an	NULL
allograft	NULL
,	NULL
a	NULL
delicate	NULL
immune	NULL
balance	NULL
is	NULL
maintained	NULL
at	NULL
the	NULL
maternal-fetal	NULL
interface	NULL
.	NULL

Locally	NULL
,	NULL
the	NULL
maternal	NULL
immune	NULL
responses	NULL
are	NULL
tightly	NULL
controlled	NULL
by	NULL
cytokines	NULL
of	NULL
maternal	NULL
and	NULL
fetal	NULL
origin	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Intraperitoneal	NULL
Address	NULL
correspondence	NULL
to	NULL
Dr.	NULL
Johannes	NULL
M.	NULL
H.	NULL
M.	NULL
Reul	NULL
,	NULL
Max-Planck-Institute	NULL
of	NULL
Psychiatry	NULL
,	NULL
Clinical	NULL
Institute	NULL
,	NULL
Department	NULL
of	NULL
Neuroendocri-nology	NULL
,	NULL
Kraepelinstrasse	NULL
2-10	NULL
,	NULL
D-80804	NULL
Munich	NULL
,	NULL
FRG	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
29	NULL
October	NULL
1993	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
4	NULL
February	NULL
1994	NULL
.	NULL

(	NULL
i.p	NULL
.	NULL
)	NULL

'	NULL
injection	NULL
of	NULL
high	NULL
doses	NULL
of	NULL
LPS	NULL
or	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
in	NULL
pregnant	NULL
rats	NULL
produces	NULL
cytotoxic	NULL
lymphocyte	NULL
invasion	NULL
,	NULL
fetal	NULL
necrosis	NULL
,	NULL
and	NULL
abortion	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
presumably	NULL
due	NULL
to	NULL
a	NULL
disturbance	NULL
of	NULL
this	NULL
immune	NULL
balance	NULL
.	NULL

However	NULL
,	NULL
in	NULL
those	NULL
cases	NULL
(	NULL
clinical	NULL
or	NULL
experimental	NULL
)	NULL
in	NULL
which	NULL
no	NULL
abortion	NULL
takes	NULL
place	NULL
,	NULL
few	NULL
data	NULL
are	NULL
available	NULL
whether	NULL
the	NULL
offspring	NULL
will	NULL
suffer	NULL
from	NULL
any	NULL
teratogenic	NULL
consequences	NULL
.	NULL

Cytokines	NULL
act	NULL
as	NULL
mediators	NULL
of	NULL
systemic	NULL
acute	NULL
phase	NULL
responses	NULL
which	NULL
are	NULL
characterized	NULL
by	NULL
rapidly	NULL
induced	NULL
changes	NULL
in	NULL
endocrinologic	NULL
,	NULL
metabolic	NULL
,	NULL
immunologic	NULL
,	NULL
and	NULL
neurologic	NULL
functions	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

These	NULL
alterations	NULL
include	NULL
induction	NULL
of	NULL
fever	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
,	NULL
hypotension	NULL
(	NULL
11	NULL
)	NULL
,	NULL
hepatic	NULL
synthesis	NULL
of	NULL
acute	NULL
phase	NULL
proteins	NULL
(	NULL
12	NULL
)	NULL
,	NULL
inhibition	NULL
of	NULL
the	NULL
hypothalamic-pituitary-gonadal	NULL
axis	NULL
(	NULL
13	NULL
)	NULL
,	NULL
and	NULL
behavioral	NULL
changes	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Cytokines	NULL
such	NULL
as	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
also	NULL
stimulate	NULL
hypothalamic-pituitary-adrenocortical	NULL
(	NULL
HPA	NULL
)	NULL
axis	NULL
activity	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
leading	NULL
to	NULL
elevated	NULL
levels	NULL
of	NULL
glucocorticoid	NULL
hormones	NULL
,	NULL
which	NULL
suppress	NULL
the	NULL
immune	NULL
response	NULL
(	NULL
18	NULL
)	NULL
.	NULL

This	NULL
circuit	NULL
between	NULL
immune	NULL
system	NULL
and	NULL
HPA	NULL
axis	NULL
has	NULL
been	NULL
considered	NULL
as	NULL
an	NULL
immuno-endocrine	NULL
feedback	NULL
loop	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Glucocorticoid	NULL
hormones	NULL
play	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
maintenance	NULL
of	NULL
homeostasis	NULL
and	NULL
a	NULL
tight	NULL
regulation	NULL
of	NULL
their	NULL
secretion	NULL
is	NULL
herein	NULL
of	NULL
utmost	NULL
importance	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
HPA	NULL
system	NULL
is	NULL
regulated	NULL
by	NULL
two	NULL
corticosteroid	NULL
receptors	NULL
in	NULL
the	NULL
brain	NULL
,	NULL
which	NULL
can	NULL
be	NULL
distinguished	NULL
as	NULL
mineralocorticoid	NULL
(	NULL
MR	NULL
)	NULL
and	NULL
glucocorticoid	NULL
receptors	NULL
(	NULL
GR	NULL
)	NULL
(	NULL
20	NULL
)	NULL
.	NULL

MR	NULL
has	NULL
a	NULL
distinct	NULL
neuroanatomical	NULL
localization	NULL
with	NULL
highest	NULL
concentrations	NULL
in	NULL
the	NULL
pyramidal	NULL
and	NULL
dentate	NULL
gyrus	NULL
neurons	NULL
of	NULL
the	NULL
hippocampus	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
GR	NULL
shows	NULL
a	NULL
ubiquitous	NULL
distribution	NULL
in	NULL
the	NULL
brain	NULL
with	NULL
high	NULL
levels	NULL
in	NULL
the	NULL
paraventricular	NULL
nucleus	NULL
of	NULL
hypothalamus	NULL
and	NULL
in	NULL
the	NULL
hippocampus	NULL
,	NULL
where	NULL
these	NULL
receptors	NULL
seem	NULL
to	NULL
be	NULL
colocalized	NULL
with	NULL
MR	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Functionally	NULL
,	NULL
limbic	NULL
(	NULL
hippocampal	NULL
)	NULL
MR	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
basal	NULL
HPA	NULL
axis	NULL
activity	NULL
,	NULL
presumably	NULL
by	NULL
a	NULL
tonic	NULL
frans-synaptic	NULL
influence	NULL
on	NULL
the	NULL
composition	NULL
and	NULL
quantities	NULL
of	NULL
corticotrophin	NULL
secretagogues	NULL
in	NULL
the	NULL
hypo-thalamic-hypophyseal	NULL
system	NULL
.	NULL

Brain	NULL
and	NULL
hypophyseal	NULL
GR	NULL
mediate	NULL
the	NULL
feedback	NULL
signal	NULL
of	NULL
elevated	NULL
glucocorticoid	NULL
levels	NULL
after	NULL
stress	NULL
or	NULL
at	NULL
the	NULL
circadian	NULL
peak	NULL
of	NULL
adrenocortical	NULL
secretion	NULL
(	NULL
20	NULL
,	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

In	NULL
concert	NULL
,	NULL
MR	NULL
and	NULL
GR	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
homeo-static	NULL
control	NULL
of	NULL
the	NULL
HPA	NULL
system	NULL
and	NULL
consequently	NULL
,	NULL
a	NULL
tight	NULL
regulation	NULL
of	NULL
these	NULL
receptor	NULL
sites	NULL
is	NULL
of	NULL
principal	NULL
importance	NULL
.	NULL

Hence	NULL
,	NULL
a	NULL
decline	NULL
in	NULL
hippocampal	NULL
corticosteroid	NULL
receptor	NULL
levels	NULL
has	NULL
been	NULL
found	NULL
often	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
a	NULL
hyperactivity	NULL
of	NULL
the	NULL
HPA	NULL
system	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

We	NULL
started	NULL
a	NULL
study	NULL
to	NULL
investigate	NULL
whether	NULL
maternal	NULL
immune	NULL
stimulation	NULL
affects	NULL
fetal	NULL
brain	NULL
development	NULL
and	NULL
causes	NULL
an	NULL
altered	NULL
HPA	NULL
axis	NULL
when	NULL
adult	NULL
.	NULL

As	NULL
immunostimulants	NULL
,	NULL
human	NULL
red	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

©	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
0021-97	NULL
$	NULL
2.00	NULL
Volume	NULL
93	NULL
,	NULL
June	NULL
1994	NULL
,	NULL
2600-2607	NULL
2600	NULL
_	NULL
Reul	NULL
et	NULL
al	NULL
.	NULL

1	NULL
.	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
ADX	NULL
,	NULL
adrenalectomy	NULL
;	NULL
CBG	NULL
,	NULL
corticosterone	NULL
binding	NULL
globulin	NULL
;	NULL
GR	NULL
,	NULL
glucocorticoid	NULL
receptor	NULL
;	NULL
HPA	NULL
,	NULL
hypo-thalamic-pituitary-adrenocortical	NULL
;	NULL
HRBC	NULL
,	NULL
human	NULL
red	NULL
blood	NULL
cells	NULL
;	NULL
i.p	NULL
.	NULL

,	NULL
intraperitoneal	NULL
;	NULL
MR	NULL
,	NULL
mineralocorticoid	NULL
receptor	NULL
.	NULL

blood	NULL
cells	NULL
(	NULL
HRBC	NULL
)	NULL
and	NULL
LPS	NULL
were	NULL
used	NULL
.	NULL

LPS	NULL
is	NULL
a	NULL
rather	NULL
unspecific	NULL
immunostimulant	NULL
acting	NULL
primarily	NULL
by	NULL
direct	NULL
stimulation	NULL
of	NULL
macrophages	NULL
,	NULL
B	NULL
cells	NULL
and	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
HRBC	NULL
activate	NULL
the	NULL
immune	NULL
system	NULL
specifically	NULL
via	NULL
T	NULL
cell-dependent	NULL
mechanisms	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
use	NULL
of	NULL
different	NULL
immunostimu-lants	NULL
permits	NULL
the	NULL
study	NULL
of	NULL
prenatal	NULL
immune	NULL
stimulation	NULL
via	NULL
alternative	NULL
(	NULL
T	NULL
cell-independent	NULL
and	NULL
T	NULL
cell-dependent	NULL
)	NULL
path-ways	NULL
,	NULL
producing	NULL
different	NULL
time	NULL
courses	NULL
of	NULL
maternal	NULL
cytokine	NULL
release	NULL
,	NULL
elevated	NULL
adrenocortical	NULL
secretion	NULL
and	NULL
other	NULL
hormonal	NULL
factors	NULL
(	NULL
27-29	NULL
)	NULL
.	NULL

This	NULL
approach	NULL
may	NULL
allow	NULL
discrimination	NULL
between	NULL
different	NULL
immune	NULL
challenges	NULL
on	NULL
fetal	NULL
brain	NULL
development	NULL
.	NULL

Methods	NULL
Animals	NULL
and	NULL
prenatal	NULL
treatment	NULL
.	NULL

Timed-pregnant	NULL
primiparous	NULL
Wistar	NULL
rats	NULL
were	NULL
purchased	NULL
from	NULL
Charles	NULL
River	NULL
Wiga	NULL
(	NULL
Sulzfeld	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
arrived	NULL
in	NULL
our	NULL
animal	NULL
room	NULL
on	NULL
their	NULL
sixth	NULL
day	NULL
of	NULL
pregnancy	NULL
.	NULL

The	NULL
day	NULL
on	NULL
which	NULL
a	NULL
vaginal	NULL
plug	NULL
was	NULL
noted	NULL
was	NULL
defined	NULL
as	NULL
the	NULL
first	NULL
day	NULL
of	NULL
gestation	NULL
.	NULL

Dams	NULL
were	NULL
housed	NULL
singly	NULL
under	NULL
standard	NULL
lighting	NULL
(	NULL
lights	NULL
on	NULL
from	NULL
0600-2000	NULL
h	NULL
)	NULL
and	NULL
temperature	NULL
(	NULL
23°C	NULL
)	NULL
conditions	NULL
.	NULL

Food	NULL
and	NULL
water	NULL
were	NULL
available	NULL
ad	NULL
libitum	NULL
.	NULL

On	NULL
day	NULL
10	NULL
of	NULL
gestation	NULL
,	NULL
relatively	NULL
early	NULL
in	NULL
fetal	NULL
rat	NULL
brain	NULL
development	NULL
(	NULL
30	NULL
)	NULL
,	NULL
these	NULL
dams	NULL
received	NULL
a	NULL
single	NULL
i.p	NULL
.	NULL

injection	NULL
of	NULL
either	NULL
30	NULL
ug/kg	NULL
LPS	NULL
or	NULL
5	NULL
x	NULL
10°	NULL
HRBC	NULL
between	NULL
10:00	NULL
and	NULL
1	NULL
1:00	NULL
a.m..	NULL
LPS	NULL
(	NULL
Escherichia	NULL
coli	NULL
026	NULL
:	NULL
B6	NULL
;	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
sterile	NULL
pyrogen-free	NULL
saline	NULL
(	NULL
9	NULL
ug	NULL
LPS/300	NULL
Ll	NULL
)	NULL
.	NULL

For	NULL
HRBC	NULL
,	NULL
blood	NULL
was	NULL
collected	NULL
in	NULL
sterile	NULL
citrate-coated	NULL
tubes	NULL
,	NULL
centrifuged	NULL
,	NULL
and	NULL
the	NULL
leucocytes	NULL
were	NULL
aspirated	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
erythrocytes	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
saline	NULL
and	NULL
resuspended	NULL
to	NULL
a	NULL
concentration	NULL
of	NULL
5	NULL
x	NULL
10°	NULL
HRBC	NULL
in	NULL
300	NULL
Ll	NULL
saline	NULL
.	NULL

Control	NULL
dams	NULL
received	NULL
an	NULL
i.p	NULL
.	NULL

injection	NULL
of	NULL
300	NULL
ul	NULL
saline	NULL
.	NULL

Gestation	NULL
lasted	NULL
for	NULL
20-22	NULL
d.	NULL
After	NULL
birth	NULL
,	NULL
male	NULL
and	NULL
female	NULL
pups	NULL
were	NULL
counted	NULL
and	NULL
litters	NULL
were	NULL
reduced	NULL
to	NULL
10	NULL
pups	NULL
per	NULL
mother	NULL
to	NULL
guarantee	NULL
similar	NULL
feeding	NULL
conditions	NULL
.	NULL

The	NULL
pups	NULL
were	NULL
weaned	NULL
at	NULL
3	NULL
wk	NULL
and	NULL
any	NULL
female	NULL
pups	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
cage	NULL
.	NULL

Only	NULL
male	NULL
rats	NULL
were	NULL
used	NULL
for	NULL
further	NULL
experimentation	NULL
.	NULL

These	NULL
rats	NULL
were	NULL
housed	NULL
six	NULL
per	NULL
cage	NULL
under	NULL
above	NULL
mentioned	NULL
conditions	NULL
and	NULL
used	NULL
for	NULL
experimentation	NULL
when	NULL
the	NULL
age	NULL
of	NULL
3	NULL
mo	NULL
was	NULL
reached	NULL
.	NULL

In	NULL
a	NULL
separate	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
the	NULL
response	NULL
of	NULL
the	NULL
maternal	NULL
immune	NULL
system	NULL
after	NULL
antigenic	NULL
stimulation	NULL
was	NULL
verified	NULL
.	NULL

Thereto	NULL
,	NULL
10-d-pregnant	NULL
rats	NULL
were	NULL
i.p	NULL
.	NULL

injected	NULL
with	NULL
HRBC	NULL
or	NULL
LPS	NULL
and	NULL
killed	NULL
after	NULL
18	NULL
d	NULL
or	NULL
3	NULL
h	NULL
,	NULL
respectively	NULL
.	NULL

Control	NULL
pregnant	NULL
rats	NULL
received	NULL
an	NULL
i.p	NULL
.	NULL

saline	NULL
injection	NULL
.	NULL

For	NULL
further	NULL
experimental	NULL
details	NULL
,	NULL
see	NULL
below	NULL
.	NULL

Measurement	NULL
of	NULL
anti-HRBC	NULL
antibodies	NULL
in	NULL
plasma	NULL
of	NULL
HRBC	NULL
-treated	NULL
pregnant	NULL
rats	NULL
.	NULL

10-d-pregnant	NULL
rats	NULL
were	NULL
injected	NULL
i.p	NULL
.	NULL

with	NULL
5	NULL
x	NULL
10°	NULL
HRBC	NULL
or	NULL
vehicle	NULL
(	NULL
pyrogen-free	NULL
sterile	NULL
saline	NULL
)	NULL
between	NULL
10:00	NULL
and	NULL
11:00	NULL
a.m.	NULL
18	NULL
d	NULL
after	NULL
injection	NULL
,	NULL
rats	NULL
were	NULL
quickly	NULL
anesthetized	NULL
with	NULL
halothane	NULL
,	NULL
decapitated	NULL
,	NULL
and	NULL
trunk	NULL
blood	NULL
was	NULL
collected	NULL
in	NULL
ice-chilled	NULL
EDT	NULL
A-coated	NULL
tubes	NULL
.	NULL

Anti-HRBC	NULL
antibody	NULL
content	NULL
in	NULL
plasma	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
whole	NULL
cell	NULL
ELISA	NULL
as	NULL
developed	NULL
by	NULL
Dr.	NULL
Wolfgang	NULL
Klinkert	NULL
(	NULL
Max	NULL
Planck	NULL
Institute	NULL
of	NULL
Psychiatry	NULL
,	NULL
Theoretical	NULL
Institute	NULL
,	NULL
Department	NULL
of	NULL
Neuroimmuno-logy	NULL
,	NULL
Martinsried	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Thereto	NULL
,	NULL
microtiter	NULL
plates	NULL
(	NULL
Costar	NULL
Corp.	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
were	NULL
coated	NULL
with	NULL
a	NULL
poly-D-lysine	NULL
solution	NULL
(	NULL
1	NULL
mg/100	NULL
ml	NULL
H	NULL
;	NULL
O	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Next	NULL
,	NULL
washed	NULL
HRBC	NULL
(	NULL
from	NULL
the	NULL
same	NULL
person	NULL
from	NULL
which	NULL
HRBC	NULL
were	NULL
collected	NULL
for	NULL
immunization	NULL
of	NULL
the	NULL
rats	NULL
)	NULL
were	NULL
added	NULL
to	NULL
each	NULL
well	NULL
(	NULL
200,000/well	NULL
)	NULL
and	NULL
the	NULL
plates	NULL
were	NULL
centrifuged	NULL
at	NULL
400	NULL
g	NULL
for	NULL
5	NULL
min	NULL
.	NULL

After	NULL
removal	NULL
of	NULL
the	NULL
supernatant	NULL
,	NULL
HRBC	NULL
were	NULL
fixed	NULL
with	NULL
0.2	NULL
%	NULL
glutaraldehyde	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
washed	NULL
two	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
blocked	NULL
with	NULL
casein	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
washed	NULL
again	NULL
two	NULL
times	NULL
with	NULL
PBS	NULL
.	NULL

Subsequently	NULL
,	NULL
diluted	NULL
test	NULL
plasmas	NULL
(	NULL
50	NULL
ul/well	NULL
)	NULL
were	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
the	NULL
incubation	NULL
,	NULL
wells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
and	NULL
endogenous	NULL
peroxydase	NULL
activity	NULL
was	NULL
blocked	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
in	NULL
methanol	NULL
(	NULL
166	NULL
ul/50	NULL
ml	NULL
methanol	NULL
;	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
)	NULL
after	NULL
which	NULL
the	NULL
wells	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
PBS	NULL
.	NULL

Next	NULL
,	NULL
peroxydase-labeled	NULL
goat	NULL
anti	NULL
Prenatal	NULL
Immune	NULL
Challenge	NULL
and	NULL
Adult	NULL
Hypothalamic-Pituitary-Adrenocortical	NULL
Axis	NULL
rat	NULL
antibody	NULL
(	NULL
DIANOVA	NULL
,	NULL
Hamburg	NULL
,	NULL
FRG	NULL
;	NULL
1	NULL
:	NULL
1,000	NULL
dilution	NULL
in	NULL
PBS	NULL
;	NULL
50	NULL
ul/well	NULL
;	NULL
this	NULL
antibody	NULL
recognizes	NULL
total	NULL
IgG	NULL
and	NULL
IgM	NULL
)	NULL
was	NULL
added	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
)	NULL
after	NULL
which	NULL
the	NULL
wells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
.	NULL

Finally	NULL
,	NULL
50	NULL
xl	NULL
substrate	NULL
solution	NULL
(	NULL
ABTS	NULL
;	NULL
2,4-Azino-bis-	NULL
[	NULL
3-Ethyl-benzthiazolin-6-sulfonacid	NULL
}	NULL
)	NULL
,	NULL
diammoniumsalt	NULL
in	NULL
substrate	NULL
buffer	NULL
(	NULL
0.1	NULL
M	NULL
citric	NULL
acid	NULL
,	NULL
0.1	NULL
M	NULL
Na	NULL
,	NULL
;	NULL
HPO	NULL
,	NULL
;	NULL
pH	NULL
4.3	NULL
;	NULL
concentration	NULL
ABTS	NULL
:	NULL
25	NULL
mg/	NULL
50	NULL
ml	NULL
buffer	NULL
)	NULL
,	NULL
and	NULL
3.4	NULL
l	NULL
H	NULL
,	NULL
O	NULL
;	NULL
were	NULL
added	NULL
,	NULL
and	NULL
optical	NULL
density	NULL
was	NULL
measured	NULL
at	NULL
405	NULL
nm	NULL
in	NULL
a	NULL
microtiter	NULL
plate	NULL
reader	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
IL-18	NULL
mRNA	NULL
in	NULL
splenocytes	NULL
of	NULL
LPS-treated	NULL
pregnant	NULL
rats	NULL
.	NULL

10-d-pregnant	NULL
rats	NULL
were	NULL
injected	NULL
i.p	NULL
.	NULL

with	NULL
30	NULL
ug/	NULL
kg	NULL
LPS	NULL
or	NULL
vehicle	NULL
(	NULL
pyrogen-free	NULL
sterile	NULL
)	NULL
saline	NULL
between	NULL
10:00	NULL
and	NULL
11:00	NULL
a.m.	NULL
3	NULL
h	NULL
after	NULL
injection	NULL
,	NULL
spleens	NULL
were	NULL
aseptically	NULL
removed	NULL
under	NULL
halothane	NULL
(	NULL
Hoechst	NULL
,	NULL
Frankfurt	NULL
am	NULL
Main	NULL
,	NULL
Germany	NULL
)	NULL
anesthesia	NULL
and	NULL
dispersed	NULL
through	NULL
a	NULL
screen	NULL
cloth	NULL
(	NULL
pore	NULL
size	NULL
40	NULL
um	NULL
)	NULL
to	NULL
obtain	NULL
single-cell	NULL
suspensions	NULL
.	NULL

Next	NULL
,	NULL
cells	NULL
were	NULL
centrifuged	NULL
(	NULL
10	NULL
min	NULL
X	NULL
400	NULL
g	NULL
,	NULL
4°C	NULL
)	NULL
,	NULL
the	NULL
pellet	NULL
resuspended	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
55	NULL
mM	NULL
NH	NULL
,	NULL
C1	NULL
,	NULL
10	NULL
mM	NULL
KHCO	NULL
;	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
)	NULL
and	NULL
maintained	NULL
on	NULL
ice	NULL
for	NULL
6	NULL
min	NULL
to	NULL
lyse	NULL
erythrocytes	NULL
.	NULL

Cells	NULL
were	NULL
separated	NULL
from	NULL
erythrocyte	NULL
fragments	NULL
by	NULL
low-speed	NULL
centrifugation	NULL
(	NULL
20	NULL
min	NULL
X	NULL
50	NULL
g	NULL
,	NULL
4°C	NULL
)	NULL
through	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
(	NULL
GIBCO	NULL
,	NULL
Paisley	NULL
,	NULL
Scotland	NULL
)	NULL
.	NULL

From	NULL
the	NULL
cell	NULL
pellet	NULL
,	NULL
total	NULL
spleen	NULL
lymphocyte	NULL
RNA	NULL
was	NULL
isolated	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Chomczynski	NULL
and	NULL
Sacchi	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Subsequent	NULL
electrophoresis	NULL
,	NULL
blotting	NULL
,	NULL
radiolabeling	NULL
of	NULL
the	NULL
rat	NULL
IL-18	NULL
probe	NULL
,	NULL
and	NULL
hybridization	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Sambrook	NULL
et	NULL
al	NULL
.	NULL

(	NULL
32	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
20	NULL
ug	NULL
RNA	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
formaldehyde	NULL
denaturing	NULL
gel	NULL
and	NULL
,	NULL
next	NULL
,	NULL
blotted	NULL
onto	NULL
nylon	NULL
membranes	NULL
(	NULL
Hybond	NULL
N	NULL
;	NULL
Amer-sham	NULL
,	NULL
Braunschweig	NULL
,	NULL
Germany	NULL
)	NULL
by	NULL
pressure	NULL
blotting	NULL
.	NULL

The	NULL
rat	NULL
IL-18	NULL
clone	NULL
which	NULL
was	NULL
inserted	NULL
in	NULL
a	NULL
SK+	NULL
Bluescript	NULL
vector	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Dan	NULL
Lindholm	NULL
(	NULL
Max	NULL
Planck	NULL
Institute	NULL
of	NULL
Psychiatry	NULL
,	NULL
Theoretical	NULL
Institute	NULL
,	NULL
Department	NULL
of	NULL
Neurochemistry	NULL
,	NULL
Martinsried	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
comprised	NULL
~	NULL
500	NULL
bp	NULL
.	NULL

The	NULL
plasmid	NULL
was	NULL
linearized	NULL
with	NULL
HindIII	NULL
,	NULL
and	NULL
a	NULL
P-labeled	NULL
cRNA	NULL
probe	NULL
was	NULL
produced	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
(	NULL
Stratagene	NULL
)	NULL
with	NULL
T3	NULL
polymerase	NULL
and	NULL
a-	NULL
P-UTP	NULL
.	NULL

Control	NULL
hybridizations	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
B-actin	NULL
cDNA	NULL
probe	NULL
which	NULL
was	NULL
generated	NULL
from	NULL
a	NULL
1-kb	NULL
-actin	NULL
cDNA	NULL
Psfl	NULL
fragment	NULL
.	NULL

This	NULL
probe	NULL
was	NULL
labeled	NULL
with	NULL
a	NULL
random-priming	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
using	NULL
a-	NULL
``	NULL
``	NULL
P-dCTP	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Nylon	NULL
membranes	NULL
were	NULL
prehybridized	NULL
for	NULL
4	NULL
h	NULL
at	NULL
42°C	NULL
in	NULL
a	NULL
solution	NULL
containing	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
5	NULL
%	NULL
sodium	NULL
chloride	NULL
sodium	NULL
phosphate	NULL
EDTA	NULL
buffer	NULL
(	NULL
SSPE	NULL
)	NULL
,	NULL
5x	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
and	NULL
100	NULL
ug/ml	NULL
denatured	NULL
salmon	NULL
sperm	NULL
DNA	NULL
and	NULL
then	NULL
hybridized	NULL
with	NULL
the	NULL
probe	NULL
at	NULL
the	NULL
same	NULL
temperature	NULL
for	NULL
15	NULL
h.	NULL
Blots	NULL
were	NULL
washed	NULL
at	NULL
increasing	NULL
salt	NULL
and	NULL
temperature	NULL
stringency	NULL
with	NULL
a	NULL
final	NULL
wash	NULL
in	NULL
0.1	NULL
%	NULL
SSC	NULL
containing	NULL
1	NULL
%	NULL
SDS	NULL
for	NULL
2	NULL
h	NULL
at	NULL
65°C	NULL
or	NULL
30	NULL
min	NULL
at	NULL
60°C	NULL
for	NULL
the	NULL
IL-18	NULL
cRNA	NULL
and	NULL
B-actin	NULL
cDNA	NULL
probe	NULL
,	NULL
respectively	NULL
.	NULL

Dried	NULL
filters	NULL
were	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
for	NULL
2-4	NULL
d	NULL
at	NULL
-70°C	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
bands	NULL
were	NULL
estimated	NULL
by	NULL
comparison	NULL
with	NULL
188	NULL
and	NULL
28S	NULL
ribosomal	NULL
RNA	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
reprobed	NULL
after	NULL
eluting	NULL
the	NULL
first	NULL
probe	NULL
with	NULL
5	NULL
mM	NULL
Tris/HCL	NULL
pH	NULL
8.0	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
for	NULL
2	NULL
h	NULL
at	NULL
70°C	NULL
.	NULL

After	NULL
the	NULL
previous	NULL
signal	NULL
was	NULL
removed	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
prehybridized	NULL
and	NULL
hybridized	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
above	NULL
.	NULL

Neuroendocrine	NULL
experiments	NULL
on	NULL
prenatally	NULL
immune-stimulated	NULL
rats	NULL
.	NULL

Each	NULL
experimental	NULL
and	NULL
control	NULL
group	NULL
was	NULL
composed	NULL
of	NULL
animals	NULL
derived	NULL
of	NULL
at	NULL
least	NULL
six	NULL
pregnant	NULL
rats	NULL
.	NULL

For	NULL
estimation	NULL
of	NULL
the	NULL
basal	NULL
plasma	NULL
levels	NULL
of	NULL
ACTH	NULL
and	NULL
corticosterone	NULL
,	NULL
great	NULL
care	NULL
was	NULL
taken	NULL
to	NULL
keep	NULL
the	NULL
rats	NULL
undisturbed	NULL
the	NULL
night	NULL
before	NULL
the	NULL
experiment	NULL
.	NULL

All	NULL
neuroendocrine	NULL
experiments	NULL
were	NULL
performed	NULL
between	NULL
7:00	NULL
and	NULL
9:00	NULL
a.m	NULL
.	NULL

Rats	NULL
were	NULL
individually	NULL
anaesthetized	NULL
(	NULL
<	NULL
25	NULL
s	NULL
)	NULL
in	NULL
a	NULL
glass	NULL
jar	NULL
containing	NULL
saturated	NULL
halothane	NULL
vapor	NULL
after	NULL
which	NULL
the	NULL
animals	NULL
were	NULL
decapitated	NULL
immediately	NULL
.	NULL

Trunk	NULL
blood	NULL
was	NULL
collected	NULL
in	NULL
ice-chilled	NULL
EDTA-coated	NULL
(	NULL
10	NULL
ml	NULL
)	NULL
tubes	NULL
containing	NULL
140	NULL
ug	NULL
aprotinin	NULL
(	NULL
Trasylol	NULL
,	NULL
Bayer	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
responses	NULL
in	NULL
plasma	NULL
ACTH	NULL
and	NULL
corticosterone	NULL
to	NULL
a	NULL
mild	NULL
stressor	NULL
were	NULL
assessed	NULL
by	NULL
exposing	NULL
rats	NULL
to	NULL
a	NULL
novel	NULL
environment	NULL
stress	NULL
procedure	NULL
.	NULL

Undisturbed	NULL
rats	NULL
were	NULL
placed	NULL
singly	NULL
in	NULL
a	NULL
new	NULL
cage	NULL
for	NULL
30	NULL
min	NULL
,	NULL
after	NULL
which	NULL
they	NULL
were	NULL
quickly	NULL
anaesthetized	NULL
,	NULL
decapitated	NULL
,	NULL
and	NULL
trunk	NULL
blood	NULL
was	NULL
collected	NULL
as	NULL
outlined	NULL
above	NULL
.	NULL

Plasma	NULL
samples	NULL
for	NULL
ACTH	NULL
and	NULL
corticosterone	NULL
measurement	NULL
by	NULL
radioimmunoassay	NULL
(	NULL
RIA	NULL
;	NULL
ICN	NULL
Biomedicals	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
were	NULL
stored	NULL
at	NULL
-80	NULL
and	NULL
-20°C	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
inter-	NULL
and	NULL
intraassay	NULL
coefficient	NULL
of	NULL
variance	NULL
for	NULL
2601	NULL
ACTH	NULL
,	NULL
were	NULL
7	NULL
and	NULL
5	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
with	NULL
a	NULL
detection	NULL
limit	NULL
of	NULL
~	NULL
2	NULL
pg/ml	NULL
.	NULL

For	NULL
corticosterone	NULL
,	NULL
the	NULL
inter-	NULL
and	NULL
intraassay	NULL
coefficient	NULL
of	NULL
variance	NULL
was	NULL
7	NULL
and	NULL
4	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
with	NULL
a	NULL
detection	NULL
limit	NULL
of	NULL
0.15	NULL
ug/100	NULL
ml	NULL
.	NULL

Surgery	NULL
and	NULL
'	NULL
H-steroid	NULL
binding	NULL
assay	NULL
on	NULL
tissues	NULL
of	NULL
prenatally	NULL
immune-stimulated	NULL
rats	NULL
.	NULL

For	NULL
corticosteroid	NULL
binding	NULL
measurement	NULL
,	NULL
rats	NULL
were	NULL
bilaterally	NULL
adrenalectomized	NULL
under	NULL
halothane	NULL
anaesthesia	NULL
to	NULL
deplete	NULL
their	NULL
body	NULL
of	NULL
endogenous	NULL
corticosteroids	NULL
.	NULL

After	NULL
surgery	NULL
,	NULL
the	NULL
animals	NULL
were	NULL
maintained	NULL
on	NULL
0.9	NULL
%	NULL
NaCl	NULL
in	NULL
the	NULL
drinking	NULL
water	NULL
.	NULL

Immediately	NULL
after	NULL
removal	NULL
from	NULL
the	NULL
body	NULL
,	NULL
adrenal	NULL
glands	NULL
were	NULL
carefully	NULL
cleaned	NULL
,	NULL
placed	NULL
in	NULL
an	NULL
eppendorf	NULL
tube	NULL
(	NULL
adrenals	NULL
of	NULL
one	NULL
rat	NULL
per	NULL
tube	NULL
)	NULL
,	NULL
and	NULL
frozen	NULL
on	NULL
dry	NULL
ice	NULL
.	NULL

The	NULL
weight	NULL
of	NULL
the	NULL
adrenals	NULL
was	NULL
determined	NULL
on	NULL
the	NULL
same	NULL
day	NULL
as	NULL
the	NULL
day	NULL
of	NULL
surgery	NULL
to	NULL
prevent	NULL
unreliable	NULL
adrenal	NULL
weight	NULL
data	NULL
due	NULL
to	NULL
water	NULL
loss	NULL
from	NULL
the	NULL
tissue	NULL
during	NULL
long-term	NULL
storage	NULL
at	NULL
-80°C	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
rats	NULL
were	NULL
weighed	NULL
at	NULL
the	NULL
time	NULL
of	NULL
adrenalec-tomy	NULL
(	NULL
ADX	NULL
)	NULL
.	NULL

One	NULL
day	NULL
after	NULL
ADX	NULL
,	NULL
rats	NULL
were	NULL
quickly	NULL
anaesthetized	NULL
with	NULL
halothane	NULL
after	NULL
which	NULL
they	NULL
were	NULL
decapitated	NULL
immediately	NULL
.	NULL

Trunk	NULL
blood	NULL
was	NULL
collected	NULL
in	NULL
pre-chilled	NULL
EDTA-coated	NULL
tubes	NULL
and	NULL
the	NULL
plasma	NULL
was	NULL
checked	NULL
for	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
endogenous	NULL
corticosterone	NULL
by	NULL
RIA	NULL
(	NULL
ICN	NULL
Biomed-icals	NULL
)	NULL
.	NULL

Immediately	NULL
after	NULL
decapitation	NULL
,	NULL
the	NULL
brain	NULL
and	NULL
the	NULL
pituitary	NULL
were	NULL
rapidly	NULL
removed	NULL
from	NULL
the	NULL
skull	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
anterior	NULL
part	NULL
of	NULL
the	NULL
pituitary	NULL
was	NULL
separated	NULL
from	NULL
the	NULL
neurointermediate	NULL
lobe	NULL
and	NULL
the	NULL
hippocampus	NULL
and	NULL
hypothalamus	NULL
were	NULL
dissected	NULL
from	NULL
the	NULL
brain	NULL
.	NULL

Dissected	NULL
tissues	NULL
were	NULL
instantaneously	NULL
frozen	NULL
on	NULL
dry	NULL
ice	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
corticosteroid	NULL
receptor	NULL
assay	NULL
.	NULL

Brain	NULL
or	NULL
pituitary	NULL
tissues	NULL
were	NULL
homogenized	NULL
(	NULL
100	NULL
mg	NULL
brain	NULL
tissue/	NULL
ml	NULL
;	NULL
50	NULL
mg	NULL
anterior	NULL
pituitary	NULL
tissue/ml	NULL
;	NULL
10	NULL
strokes	NULL
at	NULL
900	NULL
rpm	NULL
)	NULL
in	NULL
ice-cold	NULL
5	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
containing	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
molybdate	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
using	NULL
a	NULL
glass	NULL
homogenizer	NULL
with	NULL
a	NULL
Teflon	NULL
pestle	NULL
milled	NULL
at	NULL
a	NULL
clearance	NULL
of	NULL
0.25	NULL
mm	NULL
on	NULL
the	NULL
radius	NULL
.	NULL

The	NULL
homogenate	NULL
was	NULL
centrifuged	NULL
at	NULL
100,000	NULL
g	NULL
for	NULL
60	NULL
min	NULL
at	NULL
0-2°C	NULL
to	NULL
obtain	NULL
cytosol	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
supernatant	NULL
fraction	NULL
)	NULL
.	NULL

All	NULL
reagents	NULL
used	NULL
were	NULL
analytical	NULL
grade	NULL
.	NULL

For	NULL
saturation	NULL
analysis	NULL
,	NULL
aliquots	NULL
of	NULL
cytosol	NULL
(	NULL
100	NULL
ul	NULL
)	NULL
of	NULL
pooled	NULL
hippocampus	NULL
(	NULL
from	NULL
6-8	NULL
rats	NULL
per	NULL
group	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
range	NULL
of	NULL
H-labeled	NULL
steroid	NULL
concentration	NULL
(	NULL
0.1-10	NULL
nM	NULL
;	NULL
6-8	NULL
con-centrations	NULL
;	NULL
total	NULL
volume	NULL
150	NULL
1	NULL
)	NULL
in	NULL
duplicate	NULL
.	NULL

Measurements	NULL
on	NULL
individual	NULL
hippocampi	NULL
and	NULL
pooled	NULL
hypothalami	NULL
and	NULL
anterior	NULL
pituitaries	NULL
were	NULL
done	NULL
in	NULL
quintuplicate	NULL
at	NULL
a	NULL
single	NULL
concentration	NULL
(	NULL
15	NULL
nM	NULL
)	NULL
,	NULL
giving	NULL
>	NULL
95	NULL
%	NULL
saturation	NULL
of	NULL
binding	NULL
(	NULL
33-35	NULL
)	NULL
.	NULL

Measurement	NULL
of	NULL
receptors	NULL
in	NULL
individual	NULL
hypothalami	NULL
and	NULL
anterior	NULL
pituitaries	NULL
was	NULL
not	NULL
conducted	NULL
since	NULL
these	NULL
tissues	NULL
are	NULL
too	NULL
small	NULL
to	NULL
obtain	NULL
sufficient	NULL
cytosol	NULL
for	NULL
reliable	NULL
receptor	NULL
measurements	NULL
.	NULL

Receptor	NULL
measurements	NULL
on	NULL
pooled	NULL
tissues	NULL
were	NULL
repeated	NULL
at	NULL
least	NULL
three	NULL
times	NULL
to	NULL
ensure	NULL
collection	NULL
of	NULL
reproducible	NULL
data	NULL
.	NULL

Determination	NULL
of	NULL
corticosterone	NULL
binding	NULL
globulin	NULL
(	NULL
CBG	NULL
)	NULL
was	NULL
performed	NULL
in	NULL
plasma	NULL
of	NULL
individual	NULL
animals	NULL
diluted	NULL
1	NULL
in	NULL
10	NULL
,	NULL
with	NULL
25	NULL
nM	NULL
(	NULL
'HJcorticosterone	NULL
(	NULL
total	NULL
binding	NULL
)	NULL
and	NULL
25	NULL
nM	NULL
[	NULL
*HJcorticosterone	NULL
+	NULL
1,000	NULL
%	NULL
corticosterone	NULL
(	NULL
nonspecific	NULL
binding	NULL
)	NULL
determined	NULL
in	NULL
quintu-plicate	NULL
.	NULL

Total	NULL
binding	NULL
to	NULL
soluble	NULL
macromolecules	NULL
in	NULL
cytosol	NULL
was	NULL
determined	NULL
with	NULL
[	NULL
*Hjaldosterone	NULL
(	NULL
87-94	NULL
Ci/mmol	NULL
,	NULL
NEN	NULL
DuPont	NULL
,	NULL
Dreieich	NULL
,	NULL
Germany	NULL
)	NULL
or	NULL
with	NULL
(	NULL
85-106	NULL
Ci/mmol	NULL
,	NULL
Amersham	NULL
)	NULL
.	NULL

For	NULL
measurement	NULL
of	NULL
MR	NULL
,	NULL
total	NULL
binding	NULL
was	NULL
assessed	NULL
by	NULL
incubating	NULL
cytosol	NULL
with	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
the	NULL
specific	NULL
glucocorticoid	NULL
RU	NULL
28362	NULL
(	NULL
118,1789-dihydroxy-6-methyl-17a-	NULL
(	NULL
1-propionyl	NULL
)	NULL
androsta-1,4,6-triene-3-one	NULL
)	NULL
.	NULL

Unlabeled	NULL
RU	NULL
28362	NULL
was	NULL
included	NULL
to	NULL
prevent	NULL
[	NULL
*HJaldosterone	NULL
from	NULL
binding	NULL
to	NULL
GR	NULL
,	NULL
so	NULL
that	NULL
only	NULL
binding	NULL
of	NULL
this	NULL
*H-ligand	NULL
to	NULL
MR	NULL
was	NULL
measured	NULL
.	NULL

Nonspecific	NULL
binding	NULL
was	NULL
determined	NULL
in	NULL
parallel	NULL
incubations	NULL
containing	NULL
a	NULL
1,000-fold	NULL
excess	NULL
of	NULL
corticosterone	NULL
in	NULL
addition	NULL
to	NULL
cytosol	NULL
and	NULL
[	NULL
*HJaldosterone	NULL
.	NULL

Total	NULL
binding	NULL
for	NULL
the	NULL
GR	NULL
was	NULL
determined	NULL
by	NULL
incubating	NULL
cytosol	NULL
with	NULL
PH	NULL
]	NULL
}	NULL
-dexamethasone	NULL
.	NULL

Since	NULL
[	NULL
}	NULL
H	NULL
]	NULL
}	NULL
dexamethasone	NULL
also	NULL
displays	NULL
considerable	NULL
affinity	NULL
for	NULL
MR	NULL
(	NULL
36	NULL
;	NULL
I.	NULL
Stec	NULL
and	NULL
J.	NULL
M.	NULL
H.	NULL
M.	NULL
Reul	NULL
,	NULL
unpublished	NULL
observa-tion	NULL
)	NULL
,	NULL
the	NULL
fraction	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
dexamethasone	NULL
binding	NULL
to	NULL
MR	NULL
was	NULL
estimated	NULL
by	NULL
including	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
RU	NULL
28362	NULL
in	NULL
parallel	NULL
incubation	NULL
tubes	NULL
.	NULL

Nonspecific	NULL
binding	NULL
was	NULL
determined	NULL
in	NULL
parallel	NULL
incubations	NULL
containing	NULL
a	NULL
1,000-fold	NULL
excess	NULL
of	NULL
dexamethasone	NULL
in	NULL
addition	NULL
to	NULL
cytosol	NULL
and	NULL
[	NULL
PH	NULL
}	NULL
-dexamethasone	NULL
.	NULL

2602	NULL
-	NULL
Reul	NULL
et	NULL
al	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
20-24	NULL
h	NULL
at	NULL
0°C	NULL
,	NULL
bound	NULL
and	NULL
free	NULL
°H-steroid	NULL
were	NULL
separated	NULL
by	NULL
Sephadex	NULL
LH-20	NULL
(	NULL
Pharmacia	NULL
,	NULL
Sweden	NULL
)	NULL
gel	NULL
filtration	NULL
(	NULL
100	NULL
Ll	NULL
of	NULL
the	NULL
cytosol-	NULL
``	NULL
H-steroid	NULL
mixture	NULL
was	NULL
applied	NULL
to	NULL
the	NULL
LH-20	NULL
columns	NULL
)	NULL
and	NULL
radioactivity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Lowry	NULL
(	NULL
37	NULL
)	NULL
with	NULL
BSA	NULL
as	NULL
the	NULL
standard	NULL
.	NULL

The	NULL
binding	NULL
data	NULL
were	NULL
expressed	NULL
as	NULL
femtomoles	NULL
per	NULL
mg	NULL
protein	NULL
and	NULL
nonspecific	NULL
binding	NULL
was	NULL
subtracted	NULL
from	NULL
total	NULL
binding	NULL
to	NULL
yield	NULL
specific	NULL
binding	NULL
.	NULL

In	NULL
this	NULL
manner	NULL
,	NULL
the	NULL
MR	NULL
concentration	NULL
could	NULL
be	NULL
directly	NULL
measured	NULL
.	NULL

However	NULL
,	NULL
GR	NULL
binding	NULL
was	NULL
estimated	NULL
by	NULL
subtraction	NULL
of	NULL
the	NULL
specific	NULL
binding	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
dexamethasone	NULL
+	NULL
100	NULL
%	NULL
RU	NULL
28362	NULL
from	NULL
the	NULL
specific	NULL
binding	NULL
of	NULL
[	NULL
'HJdexamethasone	NULL
.	NULL

[	NULL
PH	NULL
]	NULL
-dexamethasone	NULL
+	NULL
100	NULL
%	NULL
RU	NULL
28362	NULL
rather	NULL
than	NULL
[	NULL
°HJ-aldosterone	NULL
+	NULL
100	NULL
%	NULL
X	NULL
RU	NULL
28362	NULL
binding	NULL
data	NULL
were	NULL
used	NULL
to	NULL
estimate	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
specific	NULL
[	NULL
°H	NULL
]	NULL
-dexamethasone	NULL
binding	NULL
to	NULL
MR	NULL
,	NULL
because	NULL
+	NULL
100	NULL
%	NULL
RU	NULL
28362	NULL
binding	NULL
to	NULL
MR	NULL
was	NULL
found	NULL
to	NULL
be	NULL
~	NULL
30	NULL
%	NULL
less	NULL
than	NULL
[	NULL
°HJaldosterone	NULL
+	NULL
100	NULL
%	NULL
RU	NULL
28362	NULL
binding	NULL
to	NULL
this	NULL
receptor	NULL
type	NULL
(	NULL
I.	NULL
Stec	NULL
and	NULL
J.	NULL
M.	NULL
H.	NULL
M.	NULL
Reul	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

The	NULL
maximal	NULL
number	NULL
of	NULL
binding	NULL
sites	NULL
(	NULL
B	NULL
,	NULL
,	NULL
,	NULL
,	NULL
)	NULL
and	NULL
relative	NULL
binding	NULL
affinity	NULL
(	NULL
K	NULL
,	NULL
)	NULL
were	NULL
determined	NULL
by	NULL
Scatchard	NULL
and	NULL
Woolf	NULL
analysis	NULL
.	NULL

These	NULL
experimental	NULL
protocols	NULL
were	NULL
approved	NULL
by	NULL
the	NULL
Government	NULL
of	NULL
Bavaria	NULL
,	NULL
FRG	NULL
.	NULL

Data	NULL
analysis	NULL
.	NULL

The	NULL
experimental	NULL
data	NULL
on	NULL
litter	NULL
size	NULL
,	NULL
secondary	NULL
sex	NULL
ratio	NULL
,	NULL
body	NULL
weight	NULL
,	NULL
adrenal	NULL
weight	NULL
and	NULL
receptor	NULL
binding	NULL
measurements	NULL
were	NULL
tested	NULL
for	NULL
statistically	NULL
significant	NULL
differences	NULL
with	NULL
oneway	NULL
analysis	NULL
of	NULL
variance	NULL
(	NULL
ONEWAY	NULL
)	NULL
followed	NULL
by	NULL
Duncan	NULL
multiple	NULL
range	NULL
test	NULL
in	NULL
appropriate	NULL
cases	NULL
.	NULL

Statistically	NULL
significant	NULL
differences	NULL
in	NULL
plasma	NULL
hormone	NULL
levels	NULL
were	NULL
investigated	NULL
with	NULL
the	NULL
two-tailed	NULL
Mann-Whitney	NULL
U-test	NULL
.	NULL

Data	NULL
were	NULL
considered	NULL
to	NULL
be	NULL
statistically	NULL
different	NULL
when	NULL
P	NULL
<	NULL
0.05	NULL
.	NULL

This	NULL
was	NULL
corrected	NULL
by	NULL
Bonferroni	NULL
procedure	NULL
when	NULL
multiple	NULL
comparisons	NULL
were	NULL
performed	NULL
.	NULL

Results	NULL
Effect	NULL
of	NULL
antigenic	NULL
challenge	NULL
on	NULL
the	NULL
maternal	NULL
immune	NULL
system	NULL
.	NULL

To	NULL
verify	NULL
whether	NULL
an	NULL
antigenic	NULL
challenge	NULL
with	NULL
HRBC	NULL
or	NULL
LPS	NULL
would	NULL
stimulate	NULL
the	NULL
immune	NULL
system	NULL
of	NULL
pregnant	NULL
rats	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
anti-HRBC	NULL
antibodies	NULL
in	NULL
plasma	NULL
of	NULL
HRBC	NULL
inoculated	NULL
dams	NULL
and	NULL
IL-18	NULL
mRNA	NULL
expression	NULL
in	NULL
spleen	NULL
lymphocytes	NULL
after	NULL
LPS	NULL
injection	NULL
was	NULL
determined	NULL
.	NULL

In	NULL
the	NULL
whole	NULL
cell	NULL
ELISA	NULL
with	NULL
HRBC	NULL
as	NULL
the	NULL
antigenic	NULL
sub-strate	NULL
,	NULL
it	NULL
was	NULL
found	NULL
that	NULL
plasma	NULL
of	NULL
HRBC-injected	NULL
dams	NULL
produced	NULL
substantially	NULL
higher	NULL
optical	NULL
density	NULL
values	NULL
at	NULL
plasma	NULL
dilutions	NULL
ranging	NULL
from	NULL
1:1	NULL
to	NULL
1:160	NULL
as	NULL
compared	NULL
with	NULL
values	NULL
obtained	NULL
with	NULL
serum	NULL
from	NULL
saline-injected	NULL
dams	NULL
or	NULL
rat	NULL
control	NULL
plasma	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
antigenic	NULL
stimulation	NULL
of	NULL
pregnant	NULL
rats	NULL
with	NULL
xenogeneic	NULL
blood	NULL
cells	NULL
produced	NULL
an	NULL
immune	NULL
response	NULL
giving	NULL
rise	NULL
to	NULL
the	NULL
production	NULL
of	NULL
specific	NULL
antibodies	NULL
directed	NULL
against	NULL
this	NULL
antigen	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
shows	NULL
that	NULL
,	NULL
3	NULL
h	NULL
after	NULL
i.p	NULL
.	NULL

LPS	NULL
injection	NULL
,	NULL
spleen	NULL
lymphocytes	NULL
of	NULL
pregnant	NULL
rats	NULL
expressed	NULL
markedly	NULL
increased	NULL
levels	NULL
of	NULL
IL-1	NULL
8	NULL
mRNA	NULL
,	NULL
which	NULL
is	NULL
observed	NULL
on	NULL
the	NULL
blot	NULL
as	NULL
a	NULL
single	NULL
band	NULL
with	NULL
a	NULL
length	NULL
of	NULL
~	NULL
1.8	NULL
kb	NULL
.	NULL

IL-18	NULL
mRNA	NULL
in	NULL
the	NULL
saline-injected	NULL
dams	NULL
was	NULL
hardly	NULL
detectable	NULL
,	NULL
although	NULL
similar	NULL
amounts	NULL
of	NULL
total	NULL
RNA	NULL
were	NULL
analyzed	NULL
in	NULL
each	NULL
lane	NULL
as	NULL
confirmed	NULL
by	NULL
the	NULL
signal	NULL
of	NULL
the	NULL
B-actin	NULL
mRNA	NULL
content	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
immune	NULL
stimulation	NULL
during	NULL
pregnancy	NULL
on	NULL
numeral	NULL
and	NULL
physical	NULL
parameters	NULL
of	NULL
the	NULL
offspring	NULL
.	NULL

At	NULL
birth	NULL
,	NULL
no	NULL
significant	NULL
differences	NULL
were	NULL
found	NULL
in	NULL
the	NULL
total	NULL
number	NULL
of	NULL
progeny	NULL
per	NULL
dam	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

However	NULL
,	NULL
dams	NULL
injected	NULL
with	NULL
HRBC	NULL
during	NULL
pregnancy	NULL
gave	NULL
birth	NULL
to	NULL
fewer	NULL
male	NULL
pups	NULL
than	NULL
the	NULL
control	NULL
dams	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
the	NULL
significant	NULL
decrease	NULL
of	NULL
15	NULL
%	NULL
in	NULL
the	NULL
secondary	NULL
sex	NULL
ratio	NULL
(	NULL
male	NULL
births/total	NULL
births	NULL
)	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
females	NULL
per	NULL
litter	NULL
was	NULL
not	NULL
different	NULL
among	NULL
the	NULL
experimental	NULL
groups	NULL
.	NULL

At	NULL
the	NULL
time	NULL
of	NULL
birth	NULL
,	NULL
there	NULL
were	NULL
no	NULL
differences	NULL
in	NULL
1.50	NULL
E	NULL
C	NULL
1.20	NULL
t	NULL
w	NULL
0	NULL
hus	NULL
T.	NULL
-	NULL
0.90	NULL
}	NULL
a	NULL
``	NULL
A	NULL
5	NULL
|	NULL
~	NULL
&	NULL
-	NULL
o.s0	NULL
A	NULL
&	NULL
*	NULL
,	NULL
8	NULL
be	NULL
ac	NULL
a	NULL
0.30	NULL
[	NULL
\A	NULL
A-a~	NULL
ley	NULL
kw	NULL
E.	NULL
0.00	NULL
*	NULL
*	NULL
*	NULL
0.1	NULL
1	NULL
10	NULL
100	NULL
1000	NULL
10000	NULL
Plasma	NULL
Dilution	NULL
Figure	NULL
1	NULL
.	NULL

Measurement	NULL
of	NULL
anti-HRBC	NULL
antibodies	NULL
in	NULL
plasma	NULL
of	NULL
rats	NULL
after	NULL
injection	NULL
of	NULL
HRBC	NULL
during	NULL
pregnancy	NULL
.	NULL

10-d-pregnant	NULL
rats	NULL
were	NULL
i.p	NULL
.	NULL

injected	NULL
with	NULL
5	NULL
x	NULL
10°	NULL
HRBC	NULL
or	NULL
saline	NULL
and	NULL
killed	NULL
after	NULL
18	NULL
d.	NULL
Antibodies	NULL
directed	NULL
against	NULL
HRBC	NULL
were	NULL
measured	NULL
in	NULL
plasma	NULL
using	NULL
a	NULL
whole	NULL
cell	NULL
ELISA	NULL
method	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
optical	NULL
density	NULL
at	NULL
405	NULL
nm	NULL
of	NULL
ELISA	NULL
measurements	NULL
on	NULL
1:1	NULL
to	NULL
1:2,500	NULL
diluted	NULL
plasma	NULL
of	NULL
HRBC-treated	NULL
dams	NULL
(	NULL
a	NULL
)	NULL
,	NULL
saline-treated	NULL
dams	NULL
(	NULL
a	NULL
)	NULL
,	NULL
and	NULL
on	NULL
plasma	NULL
dilutions	NULL
of	NULL
normal	NULL
control	NULL
rats	NULL
(	NULL
e	NULL
)	NULL
.	NULL

Details	NULL
on	NULL
the	NULL
ELISA	NULL
method	NULL
are	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

Data	NULL
are	NULL
shown	NULL
of	NULL
three	NULL
HRBC-injected	NULL
rats	NULL
,	NULL
two	NULL
saline-injected	NULL
animals	NULL
,	NULL
and	NULL
one	NULL
normal	NULL
control	NULL
rat	NULL
.	NULL

Each	NULL
data	NULL
point	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
measurements	NULL
.	NULL

This	NULL
figure	NULL
shows	NULL
a	NULL
specific	NULL
anti-HRBC	NULL
antibody	NULL
response	NULL
in	NULL
pregnant	NULL
rats	NULL
injected	NULL
with	NULL
HRBC	NULL
but	NULL
not	NULL
in	NULL
saline-injected	NULL
controls	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
optical	NULL
densities	NULL
obtained	NULL
with	NULL
plasma	NULL
from	NULL
saline-injected	NULL
pregnant	NULL
rats	NULL
did	NULL
not	NULL
differ	NULL
from	NULL
that	NULL
of	NULL
rat	NULL
control	NULL
plasma	NULL
.	NULL

Incubations	NULL
with	NULL
the	NULL
(	NULL
second	NULL
)	NULL
peroxydase-coupled	NULL
antibody	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
experimental	NULL
plasma	NULL
produced	NULL
only	NULL
background	NULL
levels	NULL
of	NULL
opucal	NULL
density	NULL
(	NULL
~	NULL
0.16	NULL
)	NULL
in	NULL
the	NULL
ELISA	NULL
.	NULL

body	NULL
weight	NULL
between	NULL
the	NULL
pups	NULL
of	NULL
either	NULL
sex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
male	NULL
offspring	NULL
at	NULL
the	NULL
age	NULL
of	NULL
3	NULL
mo	NULL
did	NULL
not	NULL
show	NULL
any	NULL
differences	NULL
in	NULL
either	NULL
body	NULL
weight	NULL
or	NULL
adrenal	NULL
weight	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
prenatal	NULL
immune	NULL
challenge	NULL
on	NULL
HPA	NULL
axis	NULL
activity	NULL
in	NULL
the	NULL
adult	NULL
offspring	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
prenatal	NULL
antigen	NULL
treatment	NULL
had	NULL
a	NULL
permanent	NULL
influence	NULL
on	NULL
adult	NULL
HPA	NULL
system	NULL
activity	NULL
,	NULL
we	NULL
determined	NULL
plasma	NULL
ACTH	NULL
and	NULL
corticosterone	NULL
both	NULL
under	NULL
basal	NULL
conditions	NULL
and	NULL
after	NULL
stress	NULL
.	NULL

Early	NULL
morning	NULL
basal	NULL
plasma	NULL
corticosterone	NULL
levels	NULL
were	NULL
significantly	NULL
elevated	NULL
in	NULL
both	NULL
LPS	NULL
(	NULL
+67	NULL
%	NULL
)	NULL
and	NULL
HRBC	NULL
(	NULL
+122	NULL
%	NULL
;	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
groups	NULL
.	NULL

Most	NULL
circulating	NULL
corticosterone	NULL
is	NULL
bound	NULL
to	NULL
CBG	NULL
and	NULL
albumin	NULL
but	NULL
no	NULL
significant	NULL
differences	NULL
were	NULL
found	NULL
in	NULL
CBG	NULL
levels	NULL
(	NULL
control	NULL
,	NULL
1.1	NULL
3+0.04	NULL
uM	NULL
;	NULL
LPS	NULL
,	NULL
1.07+0.03	NULL
LM	NULL
;	NULL
HRBC	NULL
,	NULL
1.10+0.03	NULL
4M	NULL
,	NULL
mean+SEM	NULL
,	NULL
n	NULL
=	NULL
7	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
in	NULL
both	NULL
LPS	NULL
and	NULL
HRBC	NULL
groups	NULL
free	NULL
corticosterone	NULL
levels	NULL
were	NULL
elevated	NULL
.	NULL

Basal	NULL
plasma	NULL
levels	NULL
of	NULL
ACTH	NULL
were	NULL
not	NULL
elevated	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
4	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
challenged	NULL
rats	NULL
respond	NULL
differently	NULL
to	NULL
stress	NULL
,	NULL
we	NULL
used	NULL
a	NULL
mild	NULL
stress	NULL
paradigm	NULL
(	NULL
30	NULL
min	NULL
in	NULL
a	NULL
novel	NULL
environment	NULL
)	NULL
.	NULL

The	NULL
HRBC	NULL
group	NULL
showed	NULL
much	NULL
larger	NULL
increases	NULL
in	NULL
plasma	NULL
levels	NULL
of	NULL
ACTH	NULL
(	NULL
+73	NULL
%	NULL
)	NULL
and	NULL
corticosterone	NULL
(	NULL
+57	NULL
%	NULL
)	NULL
than	NULL
the	NULL
control	NULL
animals	NULL
.	NULL

The	NULL
LPS	NULL
rats	NULL
showed	NULL
HPA	NULL
hormone	NULL
responses	NULL
to	NULL
stress	NULL
which	NULL
were	NULL
not	NULL
significantly	NULL
different	NULL
from	NULL
the	NULL
controls	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
prenatal	NULL
immune	NULL
challenge	NULL
on	NULL
brain	NULL
and	NULL
hypophyseal	NULL
corticosteroid	NULL
receptor	NULL
levels	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
corticosteroid	NULL
receptor	NULL
changes	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
observed	NULL
neuroendocrine	NULL
changes	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
concentration	NULL
of	NULL
MR	NULL
and	NULL
Prenatal	NULL
Immune	NULL
Challenge	NULL
and	NULL
Adult	NULL
Hypothalamic-Pituitary-Adrenocortical	NULL
Axis	NULL
Figure	NULL
2	NULL
.	NULL

IL-1B	NULL
mRNA	NULL
expression	NULL
in	NULL
spleen	NULL
lymphocytes	NULL
of	NULL
pregnant	NULL
rats	NULL
after	NULL
LPS	NULL
injection	NULL
.	NULL

Northern	NULL
blot	NULL
of	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
total	NULL
RNA	NULL
per	NULL
lane	NULL
)	NULL
extracted	NULL
from	NULL
spleen	NULL
lymphocytes	NULL
of	NULL
pregnant	NULL
rats	NULL
killed	NULL
3	NULL
h	NULL
after	NULL
i.p	NULL
.	NULL

LPS	NULL
(	NULL
30	NULL
ug/kg	NULL
body	NULL
weight	NULL
)	NULL
or	NULL
saline	NULL
injection	NULL
.	NULL

Each	NULL
lane	NULL
represents	NULL
analysis	NULL
of	NULL
pooled	NULL
spleen	NULL
lymphocyte	NULL
RNA	NULL
from	NULL
two	NULL
rats	NULL
.	NULL

(	NULL
Upper	NULL
panel	NULL
)	NULL
After	NULL
hybridizing	NULL
with	NULL
a	NULL
500	NULL
bp	NULL
P-labeled	NULL
rat	NULL
IL-18	NULL
cRNA	NULL
at	NULL
42°C	NULL
and	NULL
washing	NULL
at	NULL
high	NULL
stringency	NULL
,	NULL
the	NULL
autoradiograms	NULL
were	NULL
revealed	NULL
after	NULL
4	NULL
d	NULL
of	NULL
exposure	NULL
.	NULL

A	NULL
hybridizing	NULL
band	NULL
of	NULL
1.8	NULL
kb	NULL
indicates	NULL
markedly	NULL
higher	NULL
expression	NULL
of	NULL
IL-18	NULL
mRNA	NULL
in	NULL
spleen	NULL
lymphocytes	NULL
of	NULL
pregnant	NULL
rats	NULL
at	NULL
3	NULL
h	NULL
after	NULL
LPS	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
expression	NULL
in	NULL
saline-treated	NULL
controls	NULL
.	NULL

After	NULL
complete	NULL
elution	NULL
,	NULL
the	NULL
same	NULL
blot	NULL
was	NULL
reprobed	NULL
with	NULL
a	NULL
P-labeled	NULL
rat	NULL
cDNA	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
hybridized	NULL
and	NULL
washed	NULL
as	NULL
above	NULL
and	NULL
exposed	NULL
for	NULL
2	NULL
d.	NULL
The	NULL
signal	NULL
intensity	NULL
of	NULL
the	NULL
A-actin	NULL
mRNA	NULL
demonstrates	NULL
that	NULL
virtually	NULL
equal	NULL
amounts	NULL
of	NULL
RNA	NULL
were	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

SALINE	NULL
LPS	NULL
LPS	NULL
<	NULL
-	NULL
IL-186	NULL
~1.8kb	NULL
<	NULL
-	NULL
ACTIN	NULL
GR	NULL
in	NULL
the	NULL
hippocampus	NULL
,	NULL
and	NULL
levels	NULL
of	NULL
GR	NULL
in	NULL
hypothalamus	NULL
and	NULL
anterior	NULL
pituitary	NULL
of	NULL
the	NULL
prenatally	NULL
immune-stimulated	NULL
rats	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
4	NULL
and	NULL
C	NULL
,	NULL
both	NULL
LPS	NULL
and	NULL
HRBC	NULL
led	NULL
to	NULL
a	NULL
decrease	NULL
of	NULL
20-30	NULL
%	NULL
in	NULL
MR	NULL
levels	NULL
in	NULL
pooled	NULL
as	NULL
well	NULL
as	NULL
in	NULL
individually	NULL
measured	NULL
hippocampus	NULL
tissue	NULL
of	NULL
the	NULL
adult	NULL
offspring	NULL
.	NULL

A	NULL
decline	NULL
in	NULL
hippocampal	NULL
GR	NULL
levels	NULL
of	NULL
~	NULL
15	NULL
%	NULL
was	NULL
also	NULL
evident	NULL
in	NULL
both	NULL
treated	NULL
groups	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Saturation	NULL
binding	NULL
and	NULL
Scatchard	NULL
analysis	NULL
(	NULL
Figs	NULL
.	NULL

4	NULL
,	NULL
4	NULL
and	NULL
B	NULL
)	NULL
revealed	NULL
no	NULL
changes	NULL
in	NULL
the	NULL
K	NULL
,	NULL
of	NULL
either	NULL
MR	NULL
or	NULL
GR	NULL
.	NULL

Hypothalamic	NULL
GR	NULL
levels	NULL
were	NULL
un-changed	NULL
,	NULL
and	NULL
those	NULL
in	NULL
the	NULL
anterior	NULL
pituitary	NULL
slightly	NULL
increased	NULL
(	NULL
+	NULL
13	NULL
%	NULL
;	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

Discussion	NULL
This	NULL
study	NULL
shows	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
an	NULL
immune	NULL
challenge	NULL
during	NULL
pregnancy	NULL
affects	NULL
fetal	NULL
brain	NULL
development	NULL
which	NULL
manifests	NULL
in	NULL
a	NULL
disturbed	NULL
HPA	NULL
axis	NULL
persisting	NULL
into	NULL
adult	NULL
life	NULL
.	NULL

Hence	NULL
,	NULL
both	NULL
types	NULL
of	NULL
prenatal	NULL
immune	NULL
stimulation	NULL
led	NULL
in	NULL
the	NULL
male	NULL
offspring	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
basal	NULL
corticosterone	NULL
values	NULL
,	NULL
and	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
confrontation	NULL
of	NULL
the	NULL
prenatally	NULL
HRBC-treated	NULL
rats	NULL
to	NULL
a	NULL
psychological	NULL
stress	NULL
situation	NULL
led	NULL
to	NULL
an	NULL
augmented	NULL
response	NULL
in	NULL
plasma	NULL
ACTH	NULL
and	NULL
corticosterone	NULL
levels	NULL
.	NULL

Moreover	NULL
,	NULL
these	NULL
changes	NULL
in	NULL
hormonal	NULL
secretion	NULL
were	NULL
accompanied	NULL
by	NULL
marked	NULL
decreases	NULL
in	NULL
the	NULL
concentration	NULL
of	NULL
MR	NULL
and	NULL
GR	NULL
in	NULL
the	NULL
hippocampus	NULL
,	NULL
a	NULL
limbic	NULL
brain	NULL
structure	NULL
critical	NULL
for	NULL
processing	NULL
of	NULL
stress	NULL
and	NULL
HPA	NULL
axis	NULL
regulation	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
injection	NULL
of	NULL
LPS	NULL
or	NULL
HRBC	NULL
in	NULL
10-d-pregnant	NULL
rats	NULL
produced	NULL
inflammatory	NULL
and	NULL
immune	NULL
responses	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
IL-1	NULL
#	NULL
3	NULL
mRNA	NULL
in	NULL
spleen	NULL
lymphocytes	NULL
and	NULL
the	NULL
production	NULL
of	NULL
specific	NULL
anti-HRBC	NULL
anti-bodies	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
observations	NULL
confirm	NULL
that	NULL
the	NULL
immune	NULL
system	NULL
of	NULL
the	NULL
pregnant	NULL
animals	NULL
responded	NULL
to	NULL
the	NULL
antigenic	NULL
challenge	NULL
.	NULL

As	NULL
outlined	NULL
in	NULL
the	NULL
introduction	NULL
,	NULL
the	NULL
acute	NULL
phase	NULL
response	NULL
of	NULL
an	NULL
immune	NULL
reaction	NULL
involves	NULL
many	NULL
changes	NULL
in	NULL
metabolism	NULL
,	NULL
endocrine	NULL
system	NULL
,	NULL
immune	NULL
system	NULL
and	NULL
brain	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
one	NULL
of	NULL
these	NULL
pathophysiological	NULL
responses	NULL
or	NULL
combination	NULL
of	NULL
responses	NULL
may	NULL
have	NULL
affected	NULL
the	NULL
develop	NULL
2603	NULL
Table	NULL
I	NULL
.	NULL

Effect	NULL
of	NULL
Prenatal	NULL
Immune	NULL
Stimulation	NULL
on	NULL
the	NULL
Number	NULL
of	NULL
Offspring	NULL
and	NULL
Physical	NULL
Parameters	NULL
of	NULL
the	NULL
Adult	NULL
Male	NULL
Progeny	NULL
Prenatal	NULL
treatment	NULL
Control	NULL
LPS	NULL
HRBC	NULL
Offspring	NULL
Total	NULL
66	NULL
+	NULL
22	NULL
per	NULL
dam	NULL
13.3+0.5	NULL
(	NULL
28	NULL
)	NULL
14.74+0.7	NULL
(	NULL
17	NULL
)	NULL
13.5+0.5	NULL
(	NULL
25	NULL
)	NULL
Ratio	NULL
&	NULL
births/total	NULL
births	NULL
0.52+0.02	NULL
(	NULL
28	NULL
)	NULL
0.52+0.04	NULL
(	NULL
17	NULL
)	NULL
0.44+0.02	NULL
(	NULL
25	NULL
)	NULL
*	NULL
Male	NULL
offspring	NULL
(	NULL
3	NULL
mo	NULL
old	NULL
)	NULL
Body	NULL
weight	NULL
(	NULL
g	NULL
)	NULL
514+10	NULL
[	NULL
10	NULL
]	NULL
520+15	NULL
[	NULL
8	NULL
]	NULL
531+9	NULL
[	NULL
11	NULL
]	NULL
Adrenal	NULL
weight	NULL
(	NULL
mg	NULL
)	NULL
36.7+1.7	NULL
{	NULL
10	NULL
}	NULL
39.5+0.7	NULL
[	NULL
8	NULL
]	NULL
34.7+1.1	NULL
[	NULL
11	NULL
]	NULL
Data	NULL
on	NULL
the	NULL
offspring	NULL
of	NULL
each	NULL
experimental	NULL
group	NULL
concern	NULL
the	NULL
total	NULL
number	NULL
of	NULL
$	NULL
8	NULL
+	NULL
22	NULL
per	NULL
dam	NULL
and	NULL
the	NULL
secondary	NULL
sex	NULL
ratio	NULL
(	NULL
male	NULL
births/total	NULL
births	NULL
,	NULL
mean	NULL
+	NULL
SEM	NULL
)	NULL
,	NULL
based	NULL
on	NULL
17-28	NULL
litters	NULL
per	NULL
experimental	NULL
group	NULL
as	NULL
denoted	NULL
between	NULL
parentheses	NULL
.	NULL

The	NULL
physical	NULL
data	NULL
(	NULL
mean+SEM	NULL
)	NULL
on	NULL
the	NULL
adult	NULL
male	NULL
offspring	NULL
are	NULL
body	NULL
weight	NULL
(	NULL
expressed	NULL
as	NULL
grams	NULL
)	NULL
and	NULL
adrenal	NULL
weight	NULL
(	NULL
expressed	NULL
as	NULL
mg	NULL
per	NULL
two	NULL
adrenals	NULL
)	NULL
of	NULL
8-11	NULL
animals	NULL
(	NULL
denoted	NULL
between	NULL
brackets	NULL
)	NULL
,	NULL
derived	NULL
randomly	NULL
from	NULL
8-11	NULL
different	NULL
litters	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
10-d-pregnant	NULL
rats	NULL
received	NULL
a	NULL
single	NULL
i.p	NULL
.	NULL

injection	NULL
of	NULL
either	NULL
30	NULL
ug/kg	NULL
LPS	NULL
or	NULL
5	NULL
x	NULL
10°	NULL
HRBC	NULL
between	NULL
10:00	NULL
and	NULL
11:00	NULL
a.m.	NULL
Control	NULL
dams	NULL
received	NULL
a	NULL
saline	NULL
injection	NULL
.	NULL

After	NULL
birth	NULL
,	NULL
male	NULL
and	NULL
female	NULL
pups	NULL
were	NULL
counted	NULL
in	NULL
each	NULL
litter	NULL
and	NULL
the	NULL
secondary	NULL
sex	NULL
ratio	NULL
determined	NULL
.	NULL

Body	NULL
and	NULL
adrenal	NULL
weight	NULL
of	NULL
the	NULL
male	NULL
offspring	NULL
were	NULL
determined	NULL
at	NULL
the	NULL
age	NULL
of	NULL
3	NULL
mo	NULL
.	NULL

*	NULL
P	NULL
<	NULL
0.05	NULL
,	NULL
Duncan	NULL
multiple	NULL
range	NULL
test	NULL
.	NULL

ment	NULL
of	NULL
the	NULL
fetal	NULL
brain	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
disturbed	NULL
HPA	NULL
axis	NULL
function	NULL
when	NULL
adult	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
the	NULL
following	NULL
mechanisms	NULL
may	NULL
be	NULL
involved	NULL
.	NULL

(	NULL
a	NULL
)	NULL
The	NULL
action	NULL
of	NULL
newly	NULL
synthetized	NULL
cytokines	NULL
after	NULL
HRBC	NULL
inoculation	NULL
may	NULL
have	NULL
perturbed	NULL
the	NULL
delicate	NULL
immune	NULL
balance	NULL
maintained	NULL
at	NULL
the	NULL
feto-maternal	NULL
interface	NULL
.	NULL

Antigens	NULL
such	NULL
as	NULL
HRBC	NULL
are	NULL
thought	NULL
to	NULL
produce	NULL
cell-mediated	NULL
and	NULL
humoral	NULL
immune	NULL
responses	NULL
involving	NULL
T-helper	NULL
1	NULL
(	NULL
Ty1	NULL
)	NULL
and	NULL
T	NULL
;	NULL
2	NULL
cells	NULL
,	NULL
re	NULL
1004	NULL
|	NULL
plasma	NULL
ACTH	NULL
(	NULL
pg/ml	NULL
)	NULL
plasma	NULL
corticosterone	NULL
(	NULL
g/100	NULL
mi	NULL
)	NULL
L	NULL
]	NULL
CONTROL	NULL
LPs	NULL
-	NULL
HRBC	NULL
o	NULL
plasma	NULL
ACTH	NULL
(	NULL
pg/ml	NULL
)	NULL
plasma	NULL
corticosterone	NULL
(	NULL
ig/100	NULL
m	NULL
)	NULL
ro	NULL
o	NULL
°	NULL
~~~	NULL
control	NULL
-	NULL
urs	NULL
HRBC	NULL
m	NULL
A	NULL
.	NULL

CONTROL	NULL
_	NULL
LPS	NULL
HRBC	NULL
Figure	NULL
3	NULL
.	NULL

Plasma	NULL
levels	NULL
of	NULL
ACTH	NULL
and	NULL
corticosterone	NULL
under	NULL
early	NULL
morning	NULL
basal	NULL
resting	NULL
conditions	NULL
(	NULL
4	NULL
and	NULL
B	NULL
)	NULL
and	NULL
after	NULL
30	NULL
min	NULL
novel	NULL
environment	NULL
stress	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
in	NULL
LPS	NULL
and	NULL
HRBC	NULL
groups	NULL
(	NULL
mean+SEM	NULL
,	NULL
n	NULL
=	NULL
7-9	NULL
)	NULL
.	NULL

Each	NULL
experimental	NULL
and	NULL
control	NULL
group	NULL
was	NULL
composed	NULL
of	NULL
animals	NULL
derived	NULL
of	NULL
at	NULL
least	NULL
six	NULL
pregnant	NULL
rats	NULL
.	NULL

For	NULL
estimation	NULL
of	NULL
the	NULL
basal	NULL
plasma	NULL
levels	NULL
of	NULL
ACTH	NULL
and	NULL
corticosterone	NULL
,	NULL
great	NULL
care	NULL
was	NULL
taken	NULL
to	NULL
keep	NULL
the	NULL
rats	NULL
(	NULL
3	NULL
mo	NULL
old	NULL
)	NULL
undisturbed	NULL
during	NULL
the	NULL
night	NULL
before	NULL
the	NULL
experiment	NULL
.	NULL

All	NULL
neuroendocrine	NULL
experiments	NULL
were	NULL
performed	NULL
between	NULL
7:00	NULL
and	NULL
9:00	NULL
a.m.	NULL
After	NULL
decapitation	NULL
,	NULL
trunk	NULL
blood	NULL
was	NULL
collected	NULL
in	NULL
ice-chilled	NULL
EDTA-coated	NULL
(	NULL
10	NULL
ml	NULL
)	NULL
tubes	NULL
containing	NULL
140	NULL
ug	NULL
aprotinin	NULL
.	NULL

Changes	NULL
in	NULL
ACTH	NULL
and	NULL
corticosterone	NULL
in	NULL
response	NULL
to	NULL
psychological	NULL
stress	NULL
were	NULL
determined	NULL
by	NULL
placing	NULL
undisturbed	NULL
rats	NULL
singly	NULL
in	NULL
a	NULL
``	NULL
new	NULL
``	NULL
cage	NULL
for	NULL
30	NULL
min	NULL
,	NULL
after	NULL
which	NULL
they	NULL
were	NULL
decapitated	NULL
and	NULL
trunk	NULL
blood	NULL
was	NULL
collected	NULL
as	NULL
outlined	NULL
above	NULL
.	NULL

Plasma	NULL
ACTH	NULL
and	NULL
corticosterone	NULL
were	NULL
measured	NULL
by	NULL
RIA	NULL
.	NULL

Differences	NULL
between	NULL
means	NULL
were	NULL
tested	NULL
with	NULL
the	NULL
Mann-Whitney	NULL
U-test	NULL
.	NULL

*	NULL
,	NULL
P	NULL
<	NULL
0.025	NULL
.	NULL

2604	NULL
Reul	NULL
et	NULL
al	NULL
.	NULL

spectively	NULL
.	NULL

T1	NULL
cells	NULL
produce	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
IFN-y	NULL
,	NULL
and	NULL
TNF-	NULL
,	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
which	NULL
are	NULL
harmful	NULL
for	NULL
the	NULL
maintenance	NULL
of	NULL
the	NULL
feto-placental	NULL
unit	NULL
(	NULL
40	NULL
)	NULL
,	NULL
whereas	NULL
Ty2-derived	NULL
cytokines	NULL
(	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
IL-6	NULL
[	NULL
interleukins	NULL
involved	NULL
in	NULL
B	NULL
cell	NULL
development	NULL
;	NULL
41	NULL
]	NULL
IL-10	NULL
)	NULL
are	NULL
not	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Ty	NULL
;	NULL
1	NULL
cytokines	NULL
are	NULL
thought	NULL
to	NULL
cause	NULL
fetal	NULL
demise	NULL
by	NULL
induction	NULL
of	NULL
natural	NULL
killer	NULL
activity	NULL
and	NULL
stimulation	NULL
of	NULL
cytotoxic	NULL
lymphocyte	NULL
development	NULL
(	NULL
42	NULL
)	NULL
.	NULL

According	NULL
to	NULL
Weg-mann	NULL
et	NULL
al	NULL
.	NULL

(	NULL
42	NULL
)	NULL
,	NULL
the	NULL
maternal	NULL
immune	NULL
system	NULL
displays	NULL
enhanced	NULL
humoral	NULL
immune	NULL
responses	NULL
and	NULL
suppressed	NULL
cell-mediated	NULL
immunity	NULL
to	NULL
prevent	NULL
synthesis	NULL
of	NULL
Ty1	NULL
cytokines	NULL
.	NULL

The	NULL
Ty2	NULL
cytokine	NULL
IL-10	NULL
suppresses	NULL
cytokine	NULL
synthesis	NULL
by	NULL
T1	NULL
cells	NULL
(	NULL
38	NULL
,	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
this	NULL
apparent	NULL
shift	NULL
in	NULL
the	NULL
maternal	NULL
immune	NULL
system	NULL
from	NULL
cell-mediated	NULL
immunity	NULL
towards	NULL
humoral	NULL
responses	NULL
,	NULL
HRBC	NULL
administration	NULL
produced	NULL
effects	NULL
which	NULL
were	NULL
detrimental	NULL
for	NULL
the	NULL
developing	NULL
fetal	NULL
brain	NULL
.	NULL

IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNF-a	NULL
and	NULL
factors	NULL
that	NULL
they	NULL
secondarily	NULL
induce	NULL
are	NULL
potent	NULL
mediators	NULL
of	NULL
cell	NULL
proliferation	NULL
,	NULL
cell	NULL
differentiation	NULL
,	NULL
and	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
43-45	NULL
)	NULL
and	NULL
could	NULL
potentially	NULL
affect	NULL
developmental	NULL
processes	NULL
in	NULL
the	NULL
fetus	NULL
.	NULL

Whether	NULL
antigens	NULL
,	NULL
antigen-induced	NULL
cytokines	NULL
or	NULL
activated	NULL
lymphocytes	NULL
are	NULL
able	NULL
to	NULL
traverse	NULL
the	NULL
feto-maternal	NULL
barrier	NULL
is	NULL
still	NULL
controversial	NULL
(	NULL
26	NULL
,	NULL
46	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Endotoxemia	NULL
in	NULL
humans	NULL
and	NULL
animals	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
cause	NULL
fetal	NULL
death	NULL
and	NULL
abortion	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
and	NULL
damage	NULL
to	NULL
placental	NULL
tissue	NULL
as	NULL
well	NULL
(	NULL
6	NULL
,	NULL
47	NULL
,	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

These	NULL
effects	NULL
of	NULL
endotoxin	NULL
could	NULL
be	NULL
mimicked	NULL
by	NULL
i.p	NULL
.	NULL

injection	NULL
of	NULL
high	NULL
doses	NULL
(	NULL
>	NULL
100	NULL
ug/kg	NULL
)	NULL
of	NULL
recombinant	NULL
human	NULL
IL-la	NULL
or	NULL
TNF-a	NULL
(	NULL
6	NULL
)	NULL
.	NULL

High	NULL
concentrations	NULL
of	NULL
endotoxin	NULL
(	NULL
LPS	NULL
;	NULL
>	NULL
100	NULL
ug/kg	NULL
in	NULL
rats	NULL
or	NULL
guinea	NULL
pigs	NULL
;	NULL
>	NULL
5	NULL
ug/mouse	NULL
)	NULL
also	NULL
produce	NULL
transplacental	NULL
effects	NULL
including	NULL
fetal	NULL
growth	NULL
retardation	NULL
,	NULL
skeletal	NULL
anomalies	NULL
,	NULL
and	NULL
increased	NULL
neuronal	NULL
necrosis	NULL
(	NULL
47	NULL
,	NULL
49	NULL
,	NULL
51	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
considered	NULL
that	NULL
due	NULL
to	NULL
the	NULL
endotoxin-induced	NULL
severe	NULL
placental	NULL
ischemia	NULL
,	NULL
fetal	NULL
hypoxia	NULL
may	NULL
be	NULL
one	NULL
of	NULL
the	NULL
prime	NULL
teratogenic	NULL
mechanisms	NULL
(	NULL
47	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Hypoxia	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
cause	NULL
fetal	NULL
damage	NULL
in	NULL
many	NULL
species	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
only	NULL
a	NULL
moderate	NULL
dose	NULL
of	NULL
£	NULL
.	NULL

coli	NULL
LPS	NULL
(	NULL
30	NULL
ug/kg	NULL
)	NULL
was	NULL
used	NULL
and	NULL
no	NULL
fetal	NULL
growth	NULL
retardation	NULL
was	NULL
ob-served	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
this	NULL
dose	NULL
would	NULL
cause	NULL
placental	NULL
damage	NULL
,	NULL
it	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
maternal	NULL
fever	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
harmful	NULL
to	NULL
the	NULL
fetal	NULL
brain	NULL
(	NULL
54	NULL
)	NULL
.	NULL

LPS	NULL
as	NULL
well	NULL
as	NULL
HRBC	NULL
are	NULL
well-known	NULL
inducers	NULL
of	NULL
fever	NULL
(	NULL
10	NULL
;	NULL
A.	NULL
C.	NULL
E.	NULL
Linthorst	NULL
and	NULL
J.	NULL
M.	NULL
H.	NULL
M.	NULL
Reul	NULL
,	NULL
unpublished	NULL
observa-tions	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
we	NULL
did	NULL
not	NULL
measure	NULL
body	NULL
temperature	NULL
,	NULL
a	NULL
5001	NULL
400	NULL
7	NULL
1	NULL
2004	NULL
60	NULL
8	NULL
10	NULL
Free	NULL
(	NULL
nM	NULL
)	NULL
300	NULL
7	NULL
200	NULL
7	NULL
100	NULL
7	NULL
Bound	NULL
/	NULL
Free	NULL
(	NULL
fmol	NULL
/	NULL
mg	NULL
x	NULL
nM	NULL
~	NULL
)	NULL
0	NULL
5b	NULL
``	NULL
``	NULL
160	NULL
'	NULL
150	NULL
Bound	NULL
MR	NULL
(	NULL
fmol/mg	NULL
)	NULL
200	NULL
150	NULL
7	NULL
0	NULL
5	NULL
10	NULL
15	NULL
100	NULL
7	NULL
Free	NULL
(	NULL
nM	NULL
)	NULL
Bound	NULL
/	NULL
Free	NULL
(	NULL
fmol	NULL
/	NULL
mg	NULL
x	NULL
nM	NULL
)	NULL
504	NULL
0	NULL
u	NULL
r	NULL
v	NULL
u	NULL
v	NULL
0	NULL
50	NULL
100	NULL
150	NULL
200	NULL
250	NULL
300	NULL
Bound	NULL
GR	NULL
(	NULL
fmol/mg	NULL
)	NULL
C	NULL
200	NULL
350	NULL
MR	NULL
GR	NULL
.	NULL

300	NULL
€	NULL
ism|	NULL
~-	NULL
R	NULL
*	NULL
?	NULL

=	NULL
F	NULL
E3	NULL
E	NULL
La	NULL
ls	NULL
f	NULL
E	NULL
c	NULL
[	NULL
[	NULL
(	NULL
8	NULL
[	NULL
7	NULL
[	NULL
ff	NULL
§	NULL
g	NULL
100	NULL
“	NULL
7	NULL
g	NULL
3	NULL
//	NULL
[	NULL
ff	NULL
p	NULL
8	NULL
f	NULL
4/4	NULL
8	NULL
§	NULL
597	NULL
/	NULL
/	NULL
/	NULL
5	NULL
[	NULL
ff	NULL
f	NULL
F	NULL
CONTROL	NULL
LPS	NULL
HRBC	NULL
CONTROL	NULL
LPS	NULL
HRBC	NULL
Figure	NULL
4	NULL
.	NULL

Saturation	NULL
binding	NULL
(	NULL
inset	NULL
)	NULL
and	NULL
Scatchard	NULL
analysis	NULL
of	NULL
MR	NULL
(	NULL
4	NULL
)	NULL
and	NULL
GR	NULL
(	NULL
B	NULL
)	NULL
in	NULL
hippocampus	NULL
of	NULL
LPS	NULL
and	NULL
HRBC	NULL
groups	NULL
(	NULL
six	NULL
animals	NULL
per	NULL
group	NULL
)	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
of	NULL
a	NULL
total	NULL
of	NULL
three	NULL
is	NULL
de-picted	NULL
.	NULL

The	NULL
K	NULL
,	NULL
and	NULL
B	NULL
,	NULL
,	NULL
,	NULL
,	NULL
of	NULL
hippocampal	NULL
MR	NULL
for	NULL
binding	NULL
PH	NULL
]	NULL
-aldosterone	NULL
were	NULL
estimated	NULL
to	NULL
be	NULL
0.15	NULL
,	NULL
0.14	NULL
,	NULL
and	NULL
0.13	NULL
(	NULL
nM	NULL
)	NULL
and	NULL
133	NULL
,	NULL
96	NULL
,	NULL
and	NULL
100	NULL
(	NULL
fmol/mg	NULL
)	NULL
for	NULL
the	NULL
control	NULL
(	NULL
e	NULL
)	NULL
,	NULL
LPS	NULL
(	NULL
m	NULL
)	NULL
,	NULL
and	NULL
HRBC	NULL
(	NULL
a	NULL
)	NULL
groups	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
K	NULL
,	NULL
and	NULL
B	NULL
,	NULL
,	NULL
,	NULL
,	NULL
of	NULL
hippocampal	NULL
GR	NULL
for	NULL
PH	NULL
]	NULL
}	NULL
-dexamethasone	NULL
binding	NULL
were	NULL
estimated	NULL
to	NULL
be	NULL
1.67	NULL
,	NULL
1.62	NULL
,	NULL
and	NULL
1.59	NULL
(	NULL
nM	NULL
)	NULL
and	NULL
285	NULL
,	NULL
240	NULL
and	NULL
248	NULL
(	NULL
fmol/mg	NULL
)	NULL
for	NULL
the	NULL
control	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
HRBC	NULL
groups	NULL
,	NULL
respectively	NULL
.	NULL

C	NULL
represents	NULL
MR	NULL
and	NULL
GR	NULL
measurements	NULL
in	NULL
hippocampus	NULL
tissue	NULL
of	NULL
individual	NULL
animals	NULL
(	NULL
r	NULL
=	NULL
7-8	NULL
,	NULL
mean+SEM	NULL
)	NULL
.	NULL

Corticosteroid	NULL
receptors	NULL
were	NULL
measured	NULL
in	NULL
a	NULL
soluble	NULL
binding	NULL
assay	NULL
as	NULL
outlined	NULL
in	NULL
Methods	NULL
.	NULL

*	NULL
,	NULL
P	NULL
<	NULL
0.05	NULL
,	NULL
Duncan	NULL
multiple	NULL
range	NULL
test	NULL
.	NULL

hyperpyretic	NULL
response	NULL
in	NULL
the	NULL
maternal	NULL
animals	NULL
is	NULL
very	NULL
likely	NULL
and	NULL
may	NULL
have	NULL
contributed	NULL
to	NULL
the	NULL
anomalies	NULL
in	NULL
fetal	NULL
brain	NULL
development	NULL
.	NULL

Prenatal	NULL
Immune	NULL
Challenge	NULL
and	NULL
Adult	NULL
Hypothalamic-Pituitary-Adrenocortical	NULL
Axis	NULL
Table	NULL
II	NULL
.	NULL

Effect	NULL
of	NULL
Prenatal	NULL
Immune	NULL
Challenges	NULL
on	NULL
Hypothalamic	NULL
and	NULL
Anterior	NULL
Pituitary	NULL
Glucocorticoid	NULL
Receptors	NULL
in	NULL
Adulthood	NULL
Prenatal	NULL
treatment	NULL
Control	NULL
LPS	NULL
HRBC	NULL
Hypothalamus	NULL
GR	NULL
192+3	NULL
(	NULL
5	NULL
)	NULL
197+3	NULL
(	NULL
5	NULL
)	NULL
196+3	NULL
(	NULL
5	NULL
)	NULL
Anterior	NULL
pituitary	NULL
GR	NULL
181+2	NULL
(	NULL
5	NULL
)	NULL
202+1	NULL
(	NULL
5	NULL
)	NULL
*	NULL
206+2	NULL
(	NULL
5	NULL
)	NULL
*	NULL
GR	NULL
concentration	NULL
in	NULL
hypothalamus	NULL
and	NULL
anterior	NULL
pituitary	NULL
of	NULL
male	NULL
rats	NULL
treated	NULL
prenatally	NULL
with	NULL
saline	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
HRBC	NULL
.	NULL

Determination	NULL
of	NULL
GR	NULL
in	NULL
hypothalamus	NULL
and	NULL
anterior	NULL
pituitary	NULL
was	NULL
done	NULL
on	NULL
pooled	NULL
tissues	NULL
from	NULL
eight	NULL
rats	NULL
(	NULL
data	NULL
represent	NULL
the	NULL
mean+SEM	NULL
of	NULL
five	NULL
independent	NULL
experiments	NULL
)	NULL
.	NULL

Receptor	NULL
concentrations	NULL
are	NULL
expressed	NULL
as	NULL
fmol/mg	NULL
pro-tein	NULL
.	NULL

GR	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
soluble	NULL
binding	NULL
assay	NULL
as	NULL
outlined	NULL
in	NULL
Methods	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
,	NULL
Duncan	NULL
multiple	NULL
range	NULL
test	NULL
.	NULL

(	NULL
c	NULL
)	NULL
.	NULL

Immune	NULL
challenge-induced	NULL
changes	NULL
in	NULL
circulating	NULL
glucocorticoid	NULL
and	NULL
thyroid	NULL
hormone	NULL
levels	NULL
may	NULL
have	NULL
affected	NULL
fetal	NULL
brain	NULL
development	NULL
.	NULL

Both	NULL
glucocorticoid	NULL
(	NULL
55	NULL
)	NULL
and	NULL
thyroid	NULL
hormones	NULL
(	NULL
56	NULL
)	NULL
readily	NULL
cross	NULL
the	NULL
blood-placenta	NULL
barrier	NULL
and	NULL
for	NULL
many	NULL
years	NULL
it	NULL
has	NULL
been	NULL
known	NULL
that	NULL
glucocorticoid	NULL
and	NULL
thyroid	NULL
hormones	NULL
have	NULL
a	NULL
profound	NULL
influence	NULL
on	NULL
developmental	NULL
processes	NULL
in	NULL
fetal	NULL
brain	NULL
.	NULL

Prenatal	NULL
stress	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
changes	NULL
in	NULL
HPA	NULL
axis	NULL
activity	NULL
(	NULL
57	NULL
)	NULL
,	NULL
brain	NULL
monoamine	NULL
activity	NULL
(	NULL
58	NULL
)	NULL
,	NULL
and	NULL
behavioral	NULL
paradigms	NULL
(	NULL
59	NULL
,	NULL
60	NULL
)	NULL
in	NULL
the	NULL
adult	NULL
offspring	NULL
.	NULL

It	NULL
has	NULL
been	NULL
postulated	NULL
that	NULL
increased	NULL
maternal	NULL
glucocorticoid	NULL
secretion	NULL
underlie	NULL
these	NULL
effects	NULL
(	NULL
61	NULL
,	NULL
62	NULL
)	NULL
.	NULL

Injection	NULL
of	NULL
rats	NULL
with	NULL
xenogeneic	NULL
erythrocytes	NULL
markedly	NULL
elevates	NULL
plasma	NULL
corticosterone	NULL
levels	NULL
between	NULL
days	NULL
4	NULL
and	NULL
8	NULL
after	NULL
administration	NULL
(	NULL
27	NULL
)	NULL
,	NULL
whereas	NULL
LPS	NULL
stimulates	NULL
the	NULL
HPA	NULL
system	NULL
for	NULL
a	NULL
much	NULL
shorter	NULL
time	NULL
period	NULL
:	NULL
2-8	NULL
h	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Such	NULL
long-term	NULL
elevations	NULL
in	NULL
glucocorticoid	NULL
hormones	NULL
levels	NULL
as	NULL
occurring	NULL
after	NULL
HRBC	NULL
administra-tion	NULL
,	NULL
may	NULL
have	NULL
contributed	NULL
markedly	NULL
to	NULL
the	NULL
developmental	NULL
disturbances	NULL
reported	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Deficiencies	NULL
of	NULL
thyroid	NULL
hormones	NULL
during	NULL
the	NULL
so-called	NULL
``	NULL
criti-cal	NULL
period	NULL
``	NULL
(	NULL
in	NULL
rat	NULL
from	NULL
gestational	NULL
day	NULL
18	NULL
to	NULL
21	NULL
d	NULL
postpartum	NULL
)	NULL
(	NULL
63	NULL
)	NULL
causes	NULL
irreparable	NULL
damage	NULL
to	NULL
the	NULL
structural	NULL
development	NULL
and	NULL
organization	NULL
of	NULL
the	NULL
brain	NULL
(	NULL
64	NULL
)	NULL
.	NULL

In	NULL
humans	NULL
,	NULL
thyroid	NULL
function	NULL
is	NULL
often	NULL
altered	NULL
during	NULL
conditions	NULL
of	NULL
severe	NULL
illness	NULL
or	NULL
stress	NULL
known	NULL
as	NULL
the	NULL
``	NULL
euthyroid	NULL
sick	NULL
syndrome	NULL
``	NULL
(	NULL
65	NULL
,	NULL
66	NULL
)	NULL
.	NULL

Sick	NULL
rats	NULL
show	NULL
reduced	NULL
plasma	NULL
thyroid	NULL
stimulating	NULL
hormone	NULL
(	NULL
TSH	NULL
)	NULL
and	NULL
T	NULL
,	NULL
levels	NULL
(	NULL
67	NULL
)	NULL
.	NULL

A	NULL
decline	NULL
in	NULL
thyroid	NULL
function	NULL
was	NULL
also	NULL
observed	NULL
after	NULL
IL-1	NULL
8	NULL
administration	NULL
to	NULL
rats	NULL
(	NULL
68	NULL
)	NULL
.	NULL

In	NULL
our	NULL
studies	NULL
,	NULL
immune	NULL
stimulation	NULL
may	NULL
have	NULL
depressed	NULL
maternal	NULL
thyroid	NULL
function	NULL
thereby	NULL
compromising	NULL
fetal	NULL
brain	NULL
development	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
a	NULL
most	NULL
relevant	NULL
observation	NULL
was	NULL
that	NULL
a	NULL
T	NULL
cell-mediated	NULL
immune	NULL
response	NULL
(	NULL
HRBC	NULL
)	NULL
during	NULL
pregnancy	NULL
appeared	NULL
to	NULL
have	NULL
more	NULL
severe	NULL
implications	NULL
for	NULL
HPA	NULL
system	NULL
regulation	NULL
in	NULL
the	NULL
adult	NULL
offspring	NULL
than	NULL
prenatal	NULL
administration	NULL
of	NULL
an	NULL
endotoxic	NULL
agent	NULL
(	NULL
LPS	NULL
)	NULL
.	NULL

Although	NULL
both	NULL
prenatally	NULL
treated	NULL
groups	NULL
showed	NULL
similar	NULL
changes	NULL
in	NULL
corticosteroid	NULL
receptor	NULL
levels	NULL
in	NULL
brain	NULL
and	NULL
pituitary	NULL
,	NULL
the	NULL
observation	NULL
that	NULL
prenatal	NULL
HRBC	NULL
rats	NULL
produced	NULL
much	NULL
higher	NULL
hormonal	NULL
responses	NULL
after	NULL
stress	NULL
,	NULL
strongly	NULL
suggests	NULL
that	NULL
distinct	NULL
neuroendocrine	NULL
mechanisms	NULL
,	NULL
apart	NULL
from	NULL
the	NULL
corticosteroid	NULL
receptors	NULL
,	NULL
are	NULL
affected	NULL
by	NULL
the	NULL
prenatal	NULL
immunological	NULL
and	NULL
endotoxic	NULL
challenge	NULL
.	NULL

As	NULL
detailed	NULL
above	NULL
,	NULL
these	NULL
challenges	NULL
evoke	NULL
many	NULL
pathophysiological	NULL
changes	NULL
in	NULL
the	NULL
maternal	NULL
animal	NULL
.	NULL

It	NULL
may	NULL
be	NULL
speculated	NULL
that	NULL
the	NULL
2605	NULL
duration	NULL
of	NULL
such	NULL
antigen-induced	NULL
responses	NULL
is	NULL
determinant	NULL
for	NULL
the	NULL
extent	NULL
of	NULL
the	NULL
neuroendocrine	NULL
disorder	NULL
in	NULL
adult	NULL
life	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
relatively	NULL
long-lasting	NULL
pathophysiological	NULL
responses	NULL
after	NULL
HRBC	NULL
(	NULL
time	NULL
span	NULL
,	NULL
days	NULL
)	NULL
may	NULL
have	NULL
caused	NULL
more	NULL
damage	NULL
to	NULL
the	NULL
organization	NULL
of	NULL
neural	NULL
circuitry	NULL
underlying	NULL
HPA	NULL
axis	NULL
regulation	NULL
than	NULL
those	NULL
after	NULL
LPS	NULL
(	NULL
time	NULL
span	NULL
,	NULL
hours	NULL
)	NULL
.	NULL

Such	NULL
other	NULL
target	NULL
mechanisms	NULL
involved	NULL
in	NULL
HPA	NULL
axis	NULL
regulation	NULL
may	NULL
include	NULL
the	NULL
ascending	NULL
noradrenergic	NULL
and	NULL
serotonergic	NULL
systems	NULL
innervating	NULL
limbic	NULL
brain	NULL
areas	NULL
(	NULL
69	NULL
,	NULL
70	NULL
)	NULL
,	NULL
and	NULL
the	NULL
paraventricular	NULL
CRH	NULL
and	NULL
vasopressin	NULL
system	NULL
in	NULL
the	NULL
hypothalamus	NULL
(	NULL
71	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
required	NULL
to	NULL
discern	NULL
the	NULL
brain	NULL
mechanisms	NULL
underlying	NULL
the	NULL
HPA	NULL
axis	NULL
disturbances	NULL
after	NULL
a	NULL
prenatal	NULL
immune	NULL
challenge	NULL
.	NULL

In-terestingly	NULL
,	NULL
both	NULL
prenatal	NULL
LPS	NULL
and	NULL
HRBC	NULL
evoked	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
basal	NULL
corticosterone	NULL
values	NULL
,	NULL
but	NULL
no	NULL
changes	NULL
were	NULL
observed	NULL
in	NULL
ACTH	NULL
levels	NULL
.	NULL

This	NULL
observation	NULL
suggests	NULL
an	NULL
increased	NULL
adrenal	NULL
sensitivity	NULL
to	NULL
ACTH	NULL
in	NULL
the	NULL
prenatally	NULL
challenged	NULL
animals	NULL
,	NULL
which	NULL
may	NULL
involve	NULL
altered	NULL
splanchnic	NULL
neural	NULL
input	NULL
to	NULL
the	NULL
adrenal	NULL
(	NULL
72	NULL
)	NULL
.	NULL

Many	NULL
preclinical	NULL
and	NULL
clinical	NULL
reports	NULL
have	NULL
evidenced	NULL
that	NULL
exposure	NULL
to	NULL
elevated	NULL
glucocorticoid	NULL
levels	NULL
for	NULL
prolonged	NULL
periods	NULL
of	NULL
time	NULL
,	NULL
as	NULL
occurring	NULL
most	NULL
severely	NULL
in	NULL
the	NULL
prenatally	NULL
HRBC-treated	NULL
rats	NULL
,	NULL
are	NULL
ultimately	NULL
detrimental	NULL
for	NULL
the	NULL
organ-ism	NULL
.	NULL

Hypercorticism	NULL
has	NULL
been	NULL
observed	NULL
to	NULL
cause	NULL
immune	NULL
sup-pression	NULL
,	NULL
steroid	NULL
diabetes	NULL
,	NULL
inhibition	NULL
of	NULL
growth	NULL
,	NULL
hypertension	NULL
and	NULL
infertility	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
disturbed	NULL
HPA	NULL
axis	NULL
regulation	NULL
seems	NULL
also	NULL
to	NULL
be	NULL
implicated	NULL
in	NULL
the	NULL
precipitation	NULL
of	NULL
psychiatric	NULL
disease	NULL
,	NULL
such	NULL
as	NULL
major	NULL
depression	NULL
,	NULL
and	NULL
patients	NULL
with	NULL
Cushing	NULL
's	NULL
disease	NULL
often	NULL
suffer	NULL
from	NULL
changes	NULL
in	NULL
mood	NULL
and	NULL
affect	NULL
reminiscent	NULL
to	NULL
those	NULL
observed	NULL
in	NULL
major	NULL
depressive	NULL
illness	NULL
(	NULL
73	NULL
,	NULL
74	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
depressed	NULL
patients	NULL
with	NULL
antidepressants	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
normalize	NULL
HPA	NULL
axis	NULL
function	NULL
before	NULL
clinical	NULL
improvement	NULL
was	NULL
noted	NULL
(	NULL
75-77	NULL
)	NULL
.	NULL

The	NULL
correction	NULL
of	NULL
Cushing	NULL
's	NULL
disease	NULL
is	NULL
usually	NULL
followed	NULL
by	NULL
an	NULL
alleviation	NULL
of	NULL
the	NULL
depressive	NULL
symptoms	NULL
(	NULL
74	NULL
)	NULL
.	NULL

In	NULL
experimental	NULL
animals	NULL
,	NULL
antidepressants	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
hippocampal	NULL
expression	NULL
of	NULL
MR	NULL
and	NULL
GR	NULL
with	NULL
parallel	NULL
reductions	NULL
in	NULL
basal	NULL
and	NULL
stress-induced	NULL
ACTH	NULL
and	NULL
corticosterone	NULL
secretion	NULL
and	NULL
in	NULL
adrenal	NULL
weight	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
HPA	NULL
axis	NULL
dysfunction	NULL
appears	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
an	NULL
increased	NULL
vulnerability	NULL
for	NULL
mental	NULL
disease	NULL
in	NULL
later	NULL
live	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
to	NULL
note	NULL
that	NULL
some	NULL
epidemiological	NULL
studies	NULL
have	NULL
suggested	NULL
a	NULL
link	NULL
between	NULL
prenatal	NULL
viral	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Influenzae	NULL
A2	NULL
)	NULL
infections	NULL
and	NULL
the	NULL
pathogenesis	NULL
of	NULL
psychiatric	NULL
illness	NULL
(	NULL
78	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
pregnant	NULL
women	NULL
with	NULL
fever	NULL
and	NULL
bacteriuria	NULL
due	NULL
to	NULL
infection	NULL
with	NULL
gram-negative	NULL
organisms	NULL
give	NULL
birth	NULL
to	NULL
a	NULL
higher	NULL
incidence	NULL
of	NULL
children	NULL
with	NULL
neurologic	NULL
defects	NULL
than	NULL
do	NULL
mother	NULL
free	NULL
of	NULL
infection	NULL
(	NULL
79	NULL
,	NULL
80	NULL
)	NULL
.	NULL

The	NULL
present	NULL
study	NULL
demonstrates	NULL
that	NULL
during	NULL
pregnancy	NULL
a	NULL
T	NULL
cell-mediated	NULL
immune	NULL
reponse	NULL
as	NULL
well	NULL
as	NULL
an	NULL
endotoxic	NULL
challenge	NULL
affect	NULL
fetal	NULL
brain	NULL
development	NULL
precipitating	NULL
in	NULL
a	NULL
disturbed	NULL
HPA	NULL
system	NULL
function	NULL
in	NULL
adulthood	NULL
.	NULL

This	NULL
observation	NULL
may	NULL
open	NULL
up	NULL
new	NULL
insights	NULL
into	NULL
the	NULL
involvement	NULL
of	NULL
disordered	NULL
fetal	NULL
brain	NULL
development	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
psychiatric	NULL
disease	NULL
.	NULL

Acknowledgments	NULL
The	NULL
authors	NULL
thank	NULL
Dr.	NULL
Wolfgang	NULL
Klinkert	NULL
for	NULL
his	NULL
kind	NULL
help	NULL
regarding	NULL
the	NULL
whole	NULL
cell	NULL
ELISA	NULL
methodology	NULL
and	NULL
Dr.	NULL
Dan	NULL
Lindholm	NULL
for	NULL
his	NULL
gift	NULL
of	NULL
the	NULL
rat	NULL
IL-1§	NULL
clone	NULL
.	NULL

The	NULL
authors	NULL
acknowledge	NULL
the	NULL
expert	NULL
technical	NULL
assistance	NULL
of	NULL
Ms.	NULL
Stefanie	NULL
Andres	NULL
and	NULL
Ms.	NULL
Monika	NULL
Soder	NULL
.	NULL

The	NULL
superb	NULL
secretarial	NULL
support	NULL
by	NULL
Ms.	NULL
Elfi	NULL
Fes	NULL
!	NULL

is	NULL
also	NULL
gratefully	NULL
acknowledged	NULL
.	NULL

This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Volkswagen-Stiftung	NULL
,	NULL
Germany	NULL
,	NULL
(	NULL
grant	NULL
1/68	NULL
430	NULL
)	NULL
.	NULL

2606	NULL
Reul	NULL
et	NULL
al	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Bland	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

Influenza	NULL
in	NULL
its	NULL
relation	NULL
to	NULL
pregnancy	NULL
and	NULL
labor	NULL
.	NULL

1919	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Obstet	NULL
.	NULL

Dis	NULL
.	NULL

Wom	NULL
.	NULL

79:184-197	NULL
.	NULL

2	NULL
.	NULL

Graeff	NULL
,	NULL
H.	NULL
,	NULL
W.	NULL
Kuhn	NULL
,	NULL
and	NULL
J.	NULL
Zander	NULL
.	NULL

1973	NULL
.	NULL

Endotoxin	NULL
shock	NULL
in	NULL
obstetrics	NULL
.	NULL

In	NULL
Gram-negative	NULL
Bacterial	NULL
Infections	NULL
and	NULL
Mode	NULL
of	NULL
Endotoxin	NULL
Actions	NULL
.	NULL

Patho-physiological	NULL
,	NULL
Immunological	NULL
and	NULL
Clinical	NULL
Aspects	NULL
.	NULL

B.	NULL
Urbaschek	NULL
,	NULL
R.	NULL
Urbaschek	NULL
,	NULL
and	NULL
E.	NULL
Neter	NULL
,	NULL
editors	NULL
.	NULL

Springer-Verlag	NULL
Wein	NULL
,	NULL
Vienna	NULL
.	NULL

446-449	NULL
.	NULL

3	NULL
.	NULL

Coid	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
H.	NULL
Sandison	NULL
,	NULL
G.	NULL
Slavin	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Altman	NULL
.	NULL

1978	NULL
.	NULL

Escherichia	NULL
coli	NULL
infection	NULL
in	NULL
mice	NULL
and	NULL
impaired	NULL
fetal	NULL
development	NULL
.	NULL

Br	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Path	NULL
.	NULL

59:292-297	NULL
.	NULL

4	NULL
.	NULL

Chaouat	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
Menu	NULL
,	NULL
M.	NULL
Hofman	NULL
,	NULL
M.	NULL
Dy	NULL
,	NULL
M.	NULL
Minkowsky	NULL
,	NULL
D.	NULL
A.	NULL
Clark	NULL
,	NULL
and	NULL
T.	NULL
G.	NULL
Wegmann	NULL
.	NULL

1989	NULL
.	NULL

Lymphokines	NULL
at	NULL
the	NULL
feto	NULL
maternal	NULL
interface	NULL
affect	NULL
fetal	NULL
size	NULL
and	NULL
survival	NULL
.	NULL

Placenta	NULL
.	NULL

10:482	NULL
.	NULL

5	NULL
.	NULL

Guilbert	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
A.	NULL
Robertson	NULL
,	NULL
and	NULL
T.	NULL
G.	NULL
Wegmann	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
trophoblast	NULL
as	NULL
an	NULL
integral	NULL
component	NULL
of	NULL
a	NULL
macrophage-cytokine	NULL
network	NULL
.	NULL

Immunol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

71:49-57	NULL
.	NULL

6	NULL
.	NULL

Silen	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
A.	NULL
Firpo	NULL
,	NULL
S.	NULL
Morgello	NULL
,	NULL
S.	NULL
F.	NULL
Lowry	NULL
,	NULL
and	NULL
T.	NULL
Francus	NULL
.	NULL

1989	NULL
.	NULL

Interleukin-1a	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
cause	NULL
placental	NULL
injury	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

135:239-244	NULL
.	NULL

7	NULL
.	NULL

Tartakovsky	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
O.	NULL
Goldstein	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
cytokines	NULL
on	NULL
pregnancy	NULL
and	NULL
embryonic	NULL
development	NULL
in	NULL
mice	NULL
.	NULL

/n	NULL
The	NULL
Physiological	NULL
and	NULL
Pathological	NULL
Effects	NULL
of	NULL
Cytokines	NULL
.	NULL

C.	NULL
A.	NULL
Dinarello	NULL
,	NULL
M.	NULL
J.	NULL
Kluger	NULL
,	NULL
M.	NULL
C.	NULL
Powanda	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
,	NULL
editors	NULL
.	NULL

Wiley-Liss	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

243-248	NULL
.	NULL

8	NULL
.	NULL

Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

1984	NULL
.	NULL

Interleukin-1	NULL
.	NULL

Rev	NULL
.	NULL

Infect	NULL
.	NULL

Dis	NULL
.	NULL

6:51-95	NULL
.	NULL

9	NULL
.	NULL

Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

1988	NULL
.	NULL

Biology	NULL
of	NULL
interleukin	NULL
1	NULL
.	NULL

FASEB	NULL
(	NULL
Fed	NULL
.	NULL

Am	NULL
.	NULL

Soc	NULL
.	NULL

Exp	NULL
.	NULL

Biol	NULL
.	NULL
)	NULL

J	NULL
.	NULL

2:108-115	NULL
.	NULL

10	NULL
.	NULL

Kluger	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

1991	NULL
.	NULL

Fever	NULL
:	NULL
role	NULL
of	NULL
pyrogens	NULL
and	NULL
cryogens	NULL
.	NULL

Physio/	NULL
.	NULL

Rev	NULL
.	NULL

71:93-127	NULL
.	NULL

11	NULL
.	NULL

Okusawa	NULL
,	NULL
S.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Gelfand	NULL
,	NULL
F.	NULL
Ikejima	NULL
,	NULL
R.	NULL
J.	NULL
Connolly	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dinarello	NULL
.	NULL

1988	NULL
.	NULL

Interleukin	NULL
1	NULL
induces	NULL
a	NULL
shock-like	NULL
state	NULL
in	NULL
rabbits	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

81:1162-1172	NULL
.	NULL

12	NULL
.	NULL

Kushner	NULL
,	NULL
I	NULL
.	NULL

1982	NULL
.	NULL

The	NULL
phenomenon	NULL
of	NULL
the	NULL
acute	NULL
phase	NULL
response	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

389:39-48	NULL
.	NULL

13	NULL
.	NULL

Rivier	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
W.	NULL
Vale	NULL
.	NULL

1989	NULL
.	NULL

In	NULL
the	NULL
rat	NULL
,	NULL
interleukin-1	NULL
a	NULL
acts	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
brain	NULL
and	NULL
the	NULL
gonads	NULL
to	NULL
interfere	NULL
with	NULL
gonadotropin	NULL
and	NULL
sex	NULL
steroid	NULL
secretion	NULL
.	NULL

Endocrinology	NULL
124:2105-2109	NULL
.	NULL

14	NULL
.	NULL

Hart	NULL
,	NULL
B.	NULL
L.	NULL
1988	NULL
.	NULL

Biological	NULL
basis	NULL
of	NULL
the	NULL
behavior	NULL
of	NULL
sick	NULL
animals	NULL
.	NULL

Neurosci	NULL
.	NULL

Biobehav	NULL
.	NULL

Rev	NULL
.	NULL

12:123-137	NULL
.	NULL

15	NULL
.	NULL

Kent	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
M.	NULL
Bluthe	NULL
,	NULL
R.	NULL
Dantzer	NULL
,	NULL
A.	NULL
J.	NULL
Hardwick	NULL
,	NULL
K.	NULL
W.	NULL
Kelley	NULL
,	NULL
N.	NULL
J.	NULL
Rothwell	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Vannice	NULL
.	NULL

1992	NULL
.	NULL

Different	NULL
receptor	NULL
mechanisms	NULL
mediate	NULL
the	NULL
pyrogenic	NULL
and	NULL
behavioral	NULL
effects	NULL
of	NULL
interleukin	NULL
1	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89:9117-9120	NULL
.	NULL

16	NULL
.	NULL

Besedovsky	NULL
,	NULL
H.	NULL
,	NULL
A.	NULL
Del	NULL
Rey	NULL
,	NULL
E.	NULL
Sorkin	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dinarello	NULL
.	NULL

1986	NULL
.	NULL

Immu-noregulatory	NULL
feedback	NULL
between	NULL
interleukin-1	NULL
and	NULL
glucocorticoid	NULL
hormones	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

233:652-654	NULL
.	NULL

17	NULL
.	NULL

Bateman	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Singh	NULL
,	NULL
T.	NULL
Kral	NULL
,	NULL
and	NULL
S.	NULL
Solomon	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
immune-hy-pothalamic-pituitary-adrenal	NULL
axis	NULL
.	NULL

Endocr	NULL
.	NULL

Rev	NULL
.	NULL

10:92-112	NULL
.	NULL

18	NULL
.	NULL

Munck	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
M.	NULL
Guyre	NULL
,	NULL
and	NULL
N.	NULL
J.	NULL
Holbrook	NULL
.	NULL

1984	NULL
.	NULL

Physiological	NULL
functions	NULL
of	NULL
glucocorticoids	NULL
in	NULL
stress	NULL
and	NULL
their	NULL
relation	NULL
to	NULL
pharmacological	NULL
actions	NULL
.	NULL

Endocr	NULL
.	NULL

Rev	NULL
.	NULL

5:25-44	NULL
.	NULL

19	NULL
.	NULL

Besedovsky	NULL
,	NULL
H.	NULL
O.	NULL
and	NULL
A.	NULL
Del	NULL
Rey	NULL
.	NULL

1992	NULL
.	NULL

Immune-neurcendocrine	NULL
cir-cuits	NULL
:	NULL
integrative	NULL
role	NULL
of	NULL
cytokines	NULL
.	NULL

Front	NULL
.	NULL

Neuroendocrinol	NULL
.	NULL

13:61-94	NULL
.	NULL

20	NULL
.	NULL

Reul	NULL
,	NULL
J.	NULL
M.	NULL
H.	NULL
M.	NULL
,	NULL
and	NULL
E.	NULL
R.	NULL
De	NULL
Kloet	NULL
.	NULL

1985	NULL
.	NULL

Two	NULL
receptor	NULL
systems	NULL
for	NULL
corticosterone	NULL
in	NULL
rat	NULL
brain	NULL
:	NULL
microdistribution	NULL
and	NULL
differential	NULL
occupation	NULL
.	NULL

Endocrinology	NULL
117:2505-2512	NULL
.	NULL

21	NULL
.	NULL

Reul	NULL
,	NULL
J.	NULL
M.	NULL
H.	NULL
M.	NULL
,	NULL
and	NULL
E.	NULL
R.	NULL
De	NULL
Kloet	NULL
.	NULL

1986	NULL
.	NULL

Anatomical	NULL
resolution	NULL
of	NULL
two	NULL
types	NULL
of	NULL
corticosterone	NULL
receptor	NULL
sites	NULL
in	NULL
rat	NULL
brain	NULL
with	NULL
in	NULL
vivo	NULL
autoradiography	NULL
and	NULL
computerized	NULL
image	NULL
analysis	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

24:269-272	NULL
.	NULL

22	NULL
.	NULL

Van	NULL
Eekelen	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
M.	NULL
,	NULL
W.	NULL
Jiang	NULL
,	NULL
E.	NULL
R.	NULL
De	NULL
Kloet	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Bohn	NULL
.	NULL

1988	NULL
.	NULL

Distribution	NULL
of	NULL
the	NULL
mineralocorticoid	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
mRNAs	NULL
in	NULL
the	NULL
rat	NULL
hippocampus	NULL
.	NULL

J.	NULL
Neurosci	NULL
.	NULL

Res	NULL
.	NULL

21:88-94	NULL
.	NULL

23	NULL
.	NULL

De	NULL
Kloet	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
H.	NULL
M.	NULL
Reul	NULL
.	NULL

1987	NULL
.	NULL

Feedback	NULL
action	NULL
and	NULL
tonic	NULL
influence	NULL
of	NULL
corticosteroids	NULL
on	NULL
brain	NULL
function	NULL
:	NULL
a	NULL
concept	NULL
arising	NULL
from	NULL
the	NULL
heterogeneity	NULL
of	NULL
brain	NULL
receptor	NULL
systems	NULL
.	NULL

Psychoneuroendocrinology	NULL
.	NULL

12:83-105	NULL
.	NULL

24	NULL
.	NULL

De	NULL
Kloet	NULL
,	NULL
E.	NULL
R.	NULL
1991	NULL
.	NULL

Brain	NULL
corticosteroid	NULL
receptor	NULL
balance	NULL
and	NULL
homeo-static	NULL
control	NULL
.	NULL

Front	NULL
.	NULL

Neuroendocrinol	NULL
.	NULL

12:95-164	NULL
.	NULL

25	NULL
.	NULL

Rothuizen	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
M.	NULL
H.	NULL
M.	NULL
Reul	NULL
,	NULL
F.	NULL
J	NULL
.	NULL

Van	NULL
Sluijs	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Mol	NULL
,	NULL
A.	NULL
Rijnberk	NULL
,	NULL
and	NULL
E.	NULL
R.	NULL
De	NULL
Kloet	NULL
.	NULL

1993	NULL
.	NULL

Increased	NULL
neuroendocrine	NULL
reactivity	NULL
and	NULL
decreased	NULL
brain	NULL
mineralocorticoid	NULL
receptor-binding	NULL
capacity	NULL
in	NULL
aged	NULL
dogs	NULL
.	NULL

Endocrinology	NULL
132:161-168	NULL
.	NULL

26	NULL
.	NULL

Klein	NULL
,	NULL
J	NULL
.	NULL

1982	NULL
.	NULL

Responses	NULL
dominated	NULL
by	NULL
T	NULL
lymphocytes	NULL
.	NULL

In	NULL
Immunology	NULL
.	NULL

The	NULL
Science	NULL
of	NULL
Self-Nonself	NULL
Discrimination	NULL
.	NULL

Wiley-Interscience	NULL
,	NULL
New	NULL
York	NULL
.	NULL

445-506	NULL
.	NULL

27	NULL
.	NULL

Besedovsky	NULL
,	NULL
H.	NULL
O.	NULL
,	NULL
E.	NULL
Sorkin	NULL
,	NULL
M.	NULL
Keller	NULL
,	NULL
and	NULL
J.	NULL
Miller	NULL
.	NULL

1975	NULL
.	NULL

Changes	NULL
in	NULL
blood	NULL
hormone	NULL
levels	NULL
during	NULL
the	NULL
immune	NULL
response	NULL
(	NULL
39057	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Soc	NULL
.	NULL

Exp	NULL
.	NULL

Biol	NULL
.	NULL

Med	NULL
.	NULL

150:466-470	NULL
.	NULL

28	NULL
.	NULL

Yasuda	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Greer	NULL
.	NULL

1978	NULL
.	NULL

Evidence	NULL
that	NULL
the	NULL
hypothalamus	NULL
mediates	NULL
endotoxin	NULL
stimulation	NULL
of	NULL
adrenocorticotropic	NULL
hormone	NULL
secretion	NULL
.	NULL

Endocrinology	NULL
.	NULL

102:947-953	NULL
.	NULL

29	NULL
.	NULL

Dunn	NULL
,	NULL
A	NULL
.	NULL

1992	NULL
.	NULL

Endotoxin-induced	NULL
activation	NULL
of	NULL
cerebral	NULL
catecholamine	NULL
and	NULL
serotonin	NULL
metabolism	NULL
:	NULL
comparison	NULL
with	NULL
interleukin-1	NULL
.	NULL

J.	NULL
Pharm	NULL
.	NULL

Exp	NULL
.	NULL

Ther	NULL
.	NULL

261:964-969	NULL
.	NULL

30	NULL
.	NULL

Paxinos	NULL
,	NULL
G.	NULL
,	NULL
I.	NULL
Tork	NULL
,	NULL
L.	NULL
H.	NULL
Tecott	NULL
,	NULL
and	NULL
K.	NULL
L.	NULL
Valentino	NULL
.	NULL

1991	NULL
.	NULL

Atlas	NULL
of	NULL
the	NULL
Developing	NULL
Rat	NULL
Brain	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
London	NULL
.	NULL

31	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
.	NULL

1987	NULL
.	NULL

Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162:156-159	NULL
.	NULL

32	NULL
.	NULL

Saambrok	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
Cloning	NULL
,	NULL
a	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

33	NULL
.	NULL

Reul	NULL
,	NULL
J.	NULL
M.	NULL
H.	NULL
M.	NULL
,	NULL
I.	NULL
Stec	NULL
,	NULL
M.	NULL
Soder	NULL
,	NULL
and	NULL
F.	NULL
Holsboer	NULL
.	NULL

1993	NULL
.	NULL

Chronic	NULL
treatment	NULL
of	NULL
rats	NULL
with	NULL
the	NULL
antidepressant	NULL
amitriptyline	NULL
attenuates	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
hypothalamic-pituitary-adrenocortical	NULL
system	NULL
.	NULL

Endocrinology	NULL
.	NULL

133:312-320	NULL
.	NULL

34	NULL
.	NULL

Reul	NULL
,	NULL
J.	NULL
M.	NULL
H.	NULL
M.	NULL
,	NULL
E.	NULL
R.	NULL
de	NULL
Kloet	NULL
,	NULL
F.	NULL
J.	NULL
van	NULL
Sluijs	NULL
,	NULL
A.	NULL
Rijnberk	NULL
,	NULL
and	NULL
J.	NULL
Rothuizen	NULL
.	NULL

1990	NULL
.	NULL

Binding	NULL
characteristics	NULL
of	NULL
mineralocorticoid	NULL
and	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
dog	NULL
brain	NULL
and	NULL
pituitary	NULL
.	NULL

Endocrinology	NULL
.	NULL

127:907-915	NULL
.	NULL

35	NULL
.	NULL

Spencer	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
B.	NULL
S.	NULL
McEwen	NULL
.	NULL

1990	NULL
.	NULL

Adaptation	NULL
of	NULL
the	NULL
hypothalamic-pituitary-adrenocortical	NULL
axis	NULL
to	NULL
chronic	NULL
ethanol	NULL
stress	NULL
.	NULL

Neuroendocrinology	NULL
.	NULL

52:48	NULL
1-489	NULL
.	NULL

36	NULL
.	NULL

Spencer	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
P.	NULL
H.	NULL
Choo	NULL
,	NULL
and	NULL
B.	NULL
S.	NULL
McEwen	NULL
.	NULL

1990	NULL
.	NULL

Adrenal	NULL
steroid	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
receptor	NULL
binding	NULL
:	NULL
estimates	NULL
of	NULL
in	NULL
vivo	NULL
receptor	NULL
number	NULL
,	NULL
occupancy	NULL
,	NULL
and	NULL
activation	NULL
with	NULL
varying	NULL
level	NULL
of	NULL
steroid	NULL
.	NULL

Brain	NULL
Res	NULL
.	NULL

514:37-48	NULL
.	NULL

37	NULL
.	NULL

Lowry	NULL
,	NULL
O.	NULL
H.	NULL
,	NULL
N.	NULL
J.	NULL
Rosebrough	NULL
,	NULL
A.	NULL
L.	NULL
Farr	NULL
,	NULL
and	NULL
N.	NULL
J.	NULL
Randall	NULL
.	NULL

1951	NULL
.	NULL

Protein	NULL
measurements	NULL
with	NULL
the	NULL
Folin	NULL
phenol	NULL
reagent	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

193	NULL
;	NULL
265-275	NULL
.	NULL

38	NULL
.	NULL

Mosman	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Coffman	NULL
.	NULL

1989	NULL
.	NULL

Heterogeneity	NULL
of	NULL
Cytokine	NULL
Secretion	NULL
Patterns	NULL
and	NULL
Functions	NULL
of	NULL
Helper	NULL
T	NULL
Cells	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

46:111-147	NULL
.	NULL

39	NULL
.	NULL

Cher	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
R.	NULL
Mosmann	NULL
.	NULL

1987	NULL
.	NULL

Two	NULL
types	NULL
of	NULL
murine	NULL
helper	NULL
t	NULL
cell	NULL
clone	NULL
.	NULL

II	NULL
.	NULL

Delayed-type	NULL
hypersensitivity	NULL
is	NULL
mediated	NULL
by	NULL
T	NULL
,	NULL
,	NULL
1	NULL
clones	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

138:3688-3694	NULL
.	NULL

40	NULL
.	NULL

Chaouat	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
Menu	NULL
,	NULL
D.	NULL
A.	NULL
Clark	NULL
,	NULL
M.	NULL
Dy	NULL
,	NULL
M.	NULL
Minkowski	NULL
,	NULL
and	NULL
T.	NULL
G.	NULL
Wegmann	NULL
.	NULL

1990	NULL
.	NULL

Control	NULL
of	NULL
fetal	NULL
survival	NULL
in	NULL
CBA	NULL
x	NULL
DBA/2	NULL
mice	NULL
by	NULL
lymphokine	NULL
therapy	NULL
.	NULL

J.	NULL
Reprod	NULL
.	NULL

Fertil	NULL
.	NULL

89:447-458	NULL
.	NULL

41	NULL
.	NULL

Fiorentino	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
M.	NULL
W.	NULL
Bond	NULL
,	NULL
and	NULL
T.	NULL
R.	NULL
Mosmann	NULL
.	NULL

1989	NULL
.	NULL

Two	NULL
types	NULL
of	NULL
mouse	NULL
T	NULL
helper	NULL
cell	NULL
.	NULL

IV	NULL
.	NULL

Th2	NULL
clones	NULL
secrete	NULL
a	NULL
factor	NULL
that	NULL
inhibits	NULL
cytokine	NULL
production	NULL
by	NULL
Thi	NULL
clones	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170:2081-2095	NULL
.	NULL

42	NULL
.	NULL

Wegmann	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
H.	NULL
Lin	NULL
,	NULL
L.	NULL
Guilbert	NULL
,	NULL
and	NULL
T.	NULL
R.	NULL
Mosmann	NULL
.	NULL

1993	NULL
.	NULL

Bidirectional	NULL
cytokine	NULL
interactions	NULL
in	NULL
the	NULL
maternal-fetal	NULL
relationship	NULL
:	NULL
is	NULL
successful	NULL
pregnancy	NULL
a	NULL
T	NULL
,	NULL
,2	NULL
phenomenon	NULL
?	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

14:353-356	NULL
.	NULL

43	NULL
.	NULL

Durum	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
.	NULL

1989	NULL
.	NULL

Macrophage-derived	NULL
mediators	NULL
:	NULL
interleukin	NULL
1	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
interleukin	NULL
6	NULL
,	NULL
interferon	NULL
,	NULL
and	NULL
related	NULL
cytokines	NULL
.	NULL

/n	NULL
Fundamental	NULL
Immunology	NULL
.	NULL

W.	NULL
E.	NULL
Paul	NULL
,	NULL
editor	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

639-661	NULL
.	NULL

44	NULL
.	NULL

Balkwill	NULL
,	NULL
F.	NULL
R.	NULL
,	NULL
and	NULL
F.	NULL
Burke	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
cytokine	NULL
network	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

10:299-304	NULL
.	NULL

45	NULL
.	NULL

Di	NULL
Giovine	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Duff	NULL
.	NULL

1990	NULL
.	NULL

Interleukin	NULL
1	NULL
:	NULL
the	NULL
first	NULL
interleu-kin	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

11:13-20	NULL
.	NULL

46	NULL
.	NULL

Dahl	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
E.	NULL
Telemo	NULL
,	NULL
B.	NULL
R.	NULL
Westrom	NULL
,	NULL
I.	NULL
Jakobsson	NULL
,	NULL
and	NULL
B.	NULL
W.	NULL
Karlsson	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
passage	NULL
of	NULL
orally	NULL
fed	NULL
proteins	NULL
from	NULL
mother	NULL
to	NULL
foetus	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

Comp	NULL
.	NULL

Biochem	NULL
.	NULL

Physiol	NULL
.	NULL

77A¥:199-201	NULL
.	NULL

47	NULL
.	NULL

Ornoy	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
G.	NULL
Altshuler	NULL
.	NULL

1976	NULL
.	NULL

Maternal	NULL
endotoxemia	NULL
,	NULL
fetal	NULL
anomalies	NULL
,	NULL
and	NULL
central	NULL
nervous	NULL
system	NULL
damage	NULL
:	NULL
a	NULL
rat	NULL
model	NULL
of	NULL
a	NULL
human	NULL
problem	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Obstet	NULL
.	NULL

Gynecol	NULL
.	NULL

124:196-204	NULL
.	NULL

48	NULL
.	NULL

Hall	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
P.	NULL
W.	NULL
Jones	NULL
.	NULL

1976	NULL
.	NULL

An	NULL
experimental	NULL
study	NULL
of	NULL
Salmonella	NULL
Dublin	NULL
abortion	NULL
in	NULL
cattle	NULL
.	NULL

Br	NULL
.	NULL

Vet	NULL
.	NULL

J	NULL
.	NULL

132:60-65	NULL
.	NULL

49	NULL
.	NULL

Haesaert	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
A.	NULL
Ornoy	NULL
.	NULL

1986	NULL
.	NULL

Transplacental	NULL
effects	NULL
of	NULL
endotoxemia	NULL
on	NULL
fetal	NULL
mouse	NULL
brain	NULL
,	NULL
bone	NULL
,	NULL
and	NULL
placental	NULL
tissue	NULL
.	NULL

Pediatric	NULL
Pathol	NULL
.	NULL

5:167-181	NULL
.	NULL

50	NULL
.	NULL

Altshuler	NULL
,	NULL
G.	NULL
1993	NULL
.	NULL

Some	NULL
placental	NULL
considerations	NULL
related	NULL
to	NULL
neurodevel-opmental	NULL
and	NULL
other	NULL
disorders	NULL
.	NULL

J	NULL
.	NULL

Child	NULL
Neurol	NULL
.	NULL

8:78-94	NULL
.	NULL

51	NULL
.	NULL

Beckmann	NULL
,	NULL
I.	NULL
,	NULL
F.	NULL
Meisel-Mikolajczyk	NULL
,	NULL
P.	NULL
Leszczynski	NULL
,	NULL
M.	NULL
Brooijmans	NULL
,	NULL
and	NULL
H.	NULL
C.	NULL
S.	NULL
Wallenburg	NULL
.	NULL

1993	NULL
.	NULL

Endotoxin-induced	NULL
fetal	NULL
growth	NULL
retardation	NULL
in	NULL
the	NULL
pregnant	NULL
guinea	NULL
pig	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Obstet	NULL
.	NULL

Gynecol	NULL
.	NULL

168:714-718	NULL
.	NULL

52	NULL
.	NULL

Grabowski	NULL
,	NULL
C.	NULL
T.	NULL
1970	NULL
.	NULL

Advances	NULL
in	NULL
Teratology	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

125	NULL
pp	NULL
.	NULL

53	NULL
.	NULL

Tedeschi	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Ingalls	NULL
.	NULL

1956	NULL
.	NULL

Vascular	NULL
anomalies	NULL
of	NULL
mouse	NULL
fetuses	NULL
exposed	NULL
to	NULL
anoxia	NULL
during	NULL
pregnancy	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Obstet	NULL
.	NULL

Gynecol	NULL
.	NULL

71:16-28	NULL
.	NULL

54	NULL
.	NULL

Edwards	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
R.	NULL
H.	NULL
C.	NULL
Penny	NULL
,	NULL
and	NULL
I.	NULL
Zevnik	NULL
.	NULL

1971	NULL
.	NULL

A	NULL
brain	NULL
cell	NULL
deficit	NULL
in	NULL
newborn	NULL
guinea-pigs	NULL
following	NULL
prenatal	NULL
hyperthermia	NULL
.	NULL

Brain	NULL
Res	NULL
.	NULL

28:341-345	NULL
.	NULL

55	NULL
.	NULL

Zarrow	NULL
,	NULL
M.	NULL
X.	NULL
,	NULL
J.	NULL
E.	NULL
Philpott	NULL
,	NULL
and	NULL
V.	NULL
H.	NULL
Denenberg	NULL
.	NULL

1970	NULL
.	NULL

Passage	NULL
of	NULL
!	NULL
'	NULL

C-4-corticosterone	NULL
from	NULL
the	NULL
rat	NULL
mother	NULL
to	NULL
the	NULL
foetus	NULL
and	NULL
neonate	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

226:1058-1059	NULL
.	NULL

56	NULL
.	NULL

Morreale	NULL
de	NULL
Escobar	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
J.	NULL
Obregon	NULL
,	NULL
and	NULL
F.	NULL
Excobar	NULL
del	NULL
Rey	NULL
.	NULL

1988	NULL
.	NULL

Transfer	NULL
of	NULL
thyroid	NULL
hormones	NULL
from	NULL
the	NULL
mother	NULL
to	NULL
the	NULL
fetus	NULL
.	NULL

/n	NULL
Research	NULL
in	NULL
Con	NULL
Prenatal	NULL
Immune	NULL
Challenge	NULL
and	NULL
Adult	NULL
Hypothalamic-Pituitary-Adrenocortical	NULL
Axis	NULL
genital	NULL
Hypothyroidism	NULL
.	NULL

F.	NULL
Delang	NULL
,	NULL
D.	NULL
A.	NULL
Fisher	NULL
,	NULL
and	NULL
D.	NULL
Glinoer	NULL
,	NULL
editors	NULL
.	NULL

Ple-num	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

15-28	NULL
.	NULL

57	NULL
.	NULL

Takahashi	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
N.	NULL
H.	NULL
Kalin	NULL
,	NULL
C.	NULL
M.	NULL
Barksdale	NULL
,	NULL
and	NULL
P.	NULL
Van	NULL
den	NULL
Burgt	NULL
.	NULL

1988	NULL
.	NULL

Stressor	NULL
controllability	NULL
during	NULL
pregnancy	NULL
influences	NULL
pituitary-adrenal	NULL
hormone	NULL
concentrations	NULL
and	NULL
analgesic	NULL
responsiveness	NULL
in	NULL
offspring	NULL
.	NULL

Physiol	NULL
.	NULL

Behav	NULL
.	NULL

42:323-329	NULL
.	NULL

58	NULL
.	NULL

Moyer	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
L.	NULL
R.	NULL
Herrenkohl	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Jacobowitz	NULL
.	NULL

1978	NULL
.	NULL

Stress	NULL
during	NULL
pregnancy	NULL
:	NULL
effect	NULL
on	NULL
catecholamines	NULL
in	NULL
discrete	NULL
brain	NULL
regions	NULL
of	NULL
offspring	NULL
as	NULL
adults	NULL
.	NULL

Brain	NULL
Res	NULL
.	NULL

144	NULL
;	NULL
173-178	NULL
.	NULL

59	NULL
.	NULL

Ader	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Conklin	NULL
.	NULL

1963	NULL
.	NULL

Handling	NULL
of	NULL
pregnant	NULL
rats	NULL
:	NULL
effects	NULL
on	NULL
emotionality	NULL
of	NULL
their	NULL
offspring	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DCJ	NULL
.	NULL

142:411-412	NULL
.	NULL

60	NULL
.	NULL

Ward	NULL
,	NULL
I.	NULL
L.	NULL
1972	NULL
.	NULL

Prenatal	NULL
stress	NULL
feminizes	NULL
and	NULL
demasculinizes	NULL
the	NULL
behavior	NULL
of	NULL
males	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

175:82-84	NULL
.	NULL

61	NULL
.	NULL

Joffe	NULL
,	NULL
J.	NULL
M.	NULL
1978	NULL
.	NULL

Hormonal	NULL
mediation	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
prenatal	NULL
stress	NULL
on	NULL
offspring	NULL
behavior	NULL
.	NULL

In	NULL
Studies	NULL
on	NULL
the	NULL
Development	NULL
of	NULL
Behavior	NULL
and	NULL
the	NULL
Nervous	NULL
System	NULL
:	NULL
Early	NULL
Influences	NULL
,	NULL
Vol	NULL
.	NULL

4	NULL
.	NULL

G.	NULL
Gottlieb	NULL
,	NULL
editor	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

108-144	NULL
.	NULL

62	NULL
.	NULL

Wilke	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
S.	NULL
R.	NULL
Tseu	NULL
,	NULL
R.	NULL
W.	NULL
Rhees	NULL
,	NULL
and	NULL
D.	NULL
E.	NULL
Fleming	NULL
.	NULL

1982	NULL
.	NULL

Effects	NULL
of	NULL
environmental	NULL
stress	NULL
or	NULL
ACTH	NULL
treatment	NULL
during	NULL
pregnancy	NULL
on	NULL
maternal	NULL
and	NULL
fetal	NULL
plasma	NULL
androstenedione	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

Hormones	NULL
and	NULL
Behav	NULL
.	NULL

16:293-303	NULL
.	NULL

63	NULL
.	NULL

Dussault	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
J.	NULL
Ruel	NULL
.	NULL

1987	NULL
.	NULL

Thyroid	NULL
hormones	NULL
and	NULL
brain	NULL
development	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Physiol	NULL
.	NULL

49:321~-334	NULL
.	NULL

64	NULL
.	NULL

Porterfield	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
C.	NULL
E.	NULL
Hendrich	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
role	NULL
of	NULL
thyroid	NULL
hormones	NULL
in	NULL
prenatal	NULL
and	NULL
neonatal	NULL
neurological	NULL
development-current	NULL
perspectives	NULL
.	NULL

En-doer	NULL
.	NULL

Rev	NULL
.	NULL

14:94-106	NULL
.	NULL

65	NULL
.	NULL

Wartofsky	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
K.	NULL
D.	NULL
Burman	NULL
.	NULL

1982	NULL
.	NULL

Alterations	NULL
in	NULL
thyroid	NULL
function	NULL
in	NULL
patients	NULL
with	NULL
systemic	NULL
illness	NULL
:	NULL
the	NULL
``	NULL
euthyroid	NULL
sick	NULL
syndrome	NULL
.	NULL
``	NULL

Endocr	NULL
.	NULL

Rev	NULL
.	NULL

3:164-217	NULL
.	NULL

66	NULL
.	NULL

Burger	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
and	NULL
R.	NULL
Davies	NULL
.	NULL

1985	NULL
.	NULL

Euthyroid	NULL
low	NULL
T	NULL
;	NULL
states	NULL
.	NULL

In	NULL
Pediatric	NULL
Thyroidology	NULL
:	NULL
Pediatric	NULL
Adolescent	NULL
Endocrinolology	NULL
,	NULL
Vol	NULL
.	NULL

14	NULL
.	NULL

F.	NULL
Delange	NULL
,	NULL
D.	NULL
A.	NULL
Fisher	NULL
,	NULL
and	NULL
P.	NULL
Malvaux	NULL
,	NULL
editors	NULL
.	NULL

Karger	NULL
,	NULL
Basel	NULL
.	NULL

327-344	NULL
.	NULL

67	NULL
.	NULL

Burger	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
J.-N.	NULL
Hugues	NULL
,	NULL
and	NULL
E.	NULL
Saville	NULL
.	NULL

1981	NULL
.	NULL

Starvation	NULL
and	NULL
thyroid	NULL
function	NULL
:	NULL
effects	NULL
on	NULL
thermogenesis	NULL
and	NULL
serum	NULL
thyrotropin	NULL
.	NULL

Life	NULL
Sci	NULL
.	NULL

28:1737-1744	NULL
.	NULL

68	NULL
.	NULL

Dubuis	NULL
,	NULL
J.-M.	NULL
,	NULL
J.-M.	NULL
Dayer	NULL
,	NULL
C.	NULL
A.	NULL
Siegrist-Kaiser	NULL
,	NULL
and	NULL
A.	NULL
G.	NULL
Burger	NULL
.	NULL

1988	NULL
.	NULL

Human	NULL
recombinant	NULL
interleukin-1	NULL
8	NULL
decreases	NULL
plasma	NULL
thyroid	NULL
hormone	NULL
and	NULL
thyroid	NULL
stimulating	NULL
hormone	NULL
levels	NULL
in	NULL
rats	NULL
.	NULL

Endocrinology	NULL
.	NULL

123:2175-2181	NULL
.	NULL

69	NULL
.	NULL

Tuomisto	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
P.	NULL
Minnisto	NULL
.	NULL

1985	NULL
.	NULL

Neurotransmitter	NULL
regulation	NULL
of	NULL
anterior	NULL
pituitary	NULL
hormones	NULL
.	NULL

Pharmacol	NULL
.	NULL

Rev	NULL
.	NULL

37:249-332	NULL
.	NULL

70	NULL
.	NULL

Sawchenko	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
L.	NULL
W.	NULL
Swanson	NULL
,	NULL
H.	NULL
W.	NULL
M.	NULL
Steinbusch	NULL
,	NULL
and	NULL
A	NULL
.	NULL

A.	NULL
J.	NULL
Verhofstad	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
distribution	NULL
and	NULL
cells	NULL
of	NULL
origin	NULL
of	NULL
serotonergic	NULL
inputs	NULL
to	NULL
the	NULL
paraventricular	NULL
and	NULL
supraoptic	NULL
nuclei	NULL
of	NULL
the	NULL
rat	NULL
.	NULL

Brain	NULL
Res	NULL
.	NULL

277:355-360	NULL
.	NULL

71	NULL
.	NULL

Swanson	NULL
,	NULL
L.	NULL
W.	NULL
1987	NULL
.	NULL

The	NULL
hypothalamus	NULL
.	NULL

/n	NULL
Handbook	NULL
of	NULL
Chemical	NULL
Neuroanatomy	NULL
,	NULL
Vol	NULL
.	NULL

5	NULL
:	NULL
Integrated	NULL
Systems	NULL
of	NULL
the	NULL
CNS	NULL
,	NULL
Part	NULL
I	NULL
.	NULL

A.	NULL
Bjorklund	NULL
,	NULL
T.	NULL
Hokfeld	NULL
,	NULL
and	NULL
L.	NULL
W.	NULL
Swanson	NULL
,	NULL
editors	NULL
.	NULL

Elsevier	NULL
Science	NULL
Publishers	NULL
B.	NULL
V.	NULL
,	NULL
Amster-dam	NULL
.	NULL

1-124	NULL
.	NULL

72	NULL
.	NULL

Jasper	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
Engeland	NULL
,	NULL
W.	NULL
C..	NULL
1993	NULL
.	NULL

Splanchnicectomy	NULL
alters	NULL
diurnal	NULL
sensitivity	NULL
to	NULL
ACTH	NULL
and	NULL
abolishes	NULL
diurnal	NULL
rhythmicity	NULL
in	NULL
corticosterone	NULL
secretion	NULL
in	NULL
awake	NULL
rats	NULL
.	NULL

Proceedings	NULL
of	NULL
the	NULL
23rd	NULL
Annual	NULL
Meeting	NULL
Society	NULL
for	NULL
Neuro-science	NULL
,	NULL
Washington	NULL
D.C.	NULL
1188	NULL
.	NULL

73	NULL
.	NULL

Holsboer	NULL
,	NULL
F.	NULL
1992	NULL
.	NULL

The	NULL
hypothalamic-pituitary-adrenocortical	NULL
system	NULL
.	NULL

/n	NULL
Handbook	NULL
of	NULL
Affective	NULL
Disorders	NULL
.	NULL

E.	NULL
S.	NULL
Paykel	NULL
,	NULL
editor	NULL
.	NULL

Churchill	NULL
Livingstone/	NULL
Edinburgh	NULL
.	NULL

267-287	NULL
.	NULL

74	NULL
.	NULL

Checkley	NULL
,	NULL
S.	NULL
1992	NULL
.	NULL

Neuroendocrine	NULL
mechanisms	NULL
and	NULL
the	NULL
precipitation	NULL
of	NULL
depression	NULL
by	NULL
life	NULL
events	NULL
.	NULL

Br	NULL
.	NULL

J.	NULL
Psychiatry	NULL
.	NULL

160	NULL
(	NULL
suppl	NULL
.	NULL

15	NULL
)	NULL
.	NULL

7-17	NULL
.	NULL

75	NULL
.	NULL

Holsboer	NULL
,	NULL
F.	NULL
,	NULL
R.	NULL
Liebi	NULL
,	NULL
and	NULL
E.	NULL
Hofschuster	NULL
.	NULL

1982	NULL
.	NULL

Repeated	NULL
dexamethasone	NULL
suppression	NULL
test	NULL
during	NULL
depressive	NULL
illness	NULL
.	NULL

Normalization	NULL
of	NULL
test	NULL
result	NULL
compared	NULL
with	NULL
clinical	NULL
improvement	NULL
.	NULL

J.	NULL
Affective	NULL
Disord	NULL
.	NULL

4:93-101	NULL
.	NULL

76	NULL
.	NULL

Greden	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
R.	NULL
Gardner	NULL
,	NULL
D.	NULL
King	NULL
,	NULL
L.	NULL
Grunhaus	NULL
,	NULL
B.	NULL
J.	NULL
Carroll	NULL
,	NULL
and	NULL
Z.	NULL
Kronfold	NULL
.	NULL

1983	NULL
.	NULL

Dexamethasone	NULL
suppression	NULL
tests	NULL
in	NULL
antidepressant	NULL
treatment	NULL
of	NULL
melancholia-the	NULL
process	NULL
of	NULL
normalization	NULL
and	NULL
test-retest	NULL
reproductibility	NULL
.	NULL

Arch	NULL
.	NULL

Gen.	NULL
Psychiatry	NULL
.	NULL

40:493-500	NULL
.	NULL

77	NULL
.	NULL

Holsboer-Trachsler	NULL
,	NULL
E.	NULL
,	NULL
R.	NULL
Stohler	NULL
,	NULL
and	NULL
M.	NULL
Hatzinger	NULL
.	NULL

1991	NULL
.	NULL

Repeated	NULL
administration	NULL
of	NULL
the	NULL
combined	NULL
dexamethasone/hCRH	NULL
stimulation	NULL
test	NULL
during	NULL
treatment	NULL
of	NULL
depression	NULL
.	NULL

Psychiatry	NULL
Res	NULL
.	NULL

38:163-171	NULL
.	NULL

78	NULL
.	NULL

O'Callaghan	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Sham	NULL
,	NULL
N.	NULL
Takei	NULL
,	NULL
G.	NULL
Glover	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Murray	NULL
.	NULL

1991	NULL
.	NULL

Schizophrenia	NULL
after	NULL
prenatal	NULL
exposure	NULL
to	NULL
1957	NULL
A2	NULL
influenza	NULL
epidemic	NULL
.	NULL

Lancet	NULL
.	NULL

137:1248-1250	NULL
.	NULL

79	NULL
.	NULL

Patrick	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

1967	NULL
.	NULL

Influence	NULL
of	NULL
maternal	NULL
renal	NULL
infection	NULL
on	NULL
the	NULL
foetus	NULL
and	NULL
infant	NULL
.	NULL

Arch	NULL
.	NULL

Dis	NULL
.	NULL

Child	NULL
.	NULL

42:208-213	NULL
.	NULL

80	NULL
.	NULL

Niswander	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
Gordon	NULL
.	NULL

1972	NULL
.	NULL

The	NULL
Women	NULL
and	NULL
Their	NULL
Pregnan-cies	NULL
.	NULL

The	NULL
Collaborative	NULL
Perinatal	NULL
Study	NULL
of	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Neurological	NULL
Diseases	NULL
and	NULL
Stroke	NULL
.	NULL

W.	NULL
B.	NULL
Saunders	NULL
Company	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA.	NULL
252-256	NULL
.	NULL

2607	NULL

